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Abstract 
A molecular depiction of the assembly, interaction and regulation of protein 
complexes is essential to the understanding of biological functions of protein complexes. 
Structural analysis of protein complexes by Nuclear Magnetic Resonance (NMR) has 
relied heavily on the detection and assignment of intermolecular Nuclear Overhauser 
Effects (NOEs) that define the interactions of protons at the molecular interface. 
Intermolecular NOEs have traditionally been detected from 3-D half-filtered NOE 
experiments by suppressing intramolecular NOEs prior to NOE transfer. However, due 
to insufficient suppression of undesirable signals and a lack of dispersion in the H 
dimension, data analysis is complicated by the interference of residual intramolecular 
NOEs and assignment ambiguity, both of which can lead to distorted or even 
erroneously packed protein complex structures. Leveraging the recent development of 
fast NMR technology based on sparse sampling in our lab, we developed a strategy for 
reliable identification and assignment of intermolecular NOEs using high resolution 4-D 
NOE difference spectroscopy. Spectral subtraction of individually labeled components 
from a uniformly labeled protein complex yields an “omit” spectrum containing only 
intermolecular NOEs with little signal degeneracy.  
The benefit of such a strategy is first demonstrated in structural analysis of a 
homooligomeric protein complexes, the foldon trimer. We show that intermolecular 
NOEs collected from the 4-D omit NOE spectrum can be directly utilized for automated 
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structural analysis of the foldon trimer by CYANA, whereas intermolecular NOEs 
derived from 3-D half-filtered NOE experiments failed to generate a converged structure 
under the same condition.  
Such a strategy was further demonstrated on a heterodimeric protein complex in 
translesion sysnthesis (TLS), a DNA damage tolerance pathway. The TLS machinery 
consists of several translesion DNA polymerases that are recruited to the stalled 
replication fork in response to monoubiquitinated proliferating cell nuclear antigen 
(PCNA) in order to bypass DNA lesions encountered during genomic replication. The 
recruitment and assembly of translesion machinery is heavily dependent on ubiquitin-
binding domains, including ubiquitin-binding motifs (UBMs) and ubiquitin-binding 
zinc fingers (UBZs) that are found in translesion DNA polymerases. Two conserved 
ubiquitin-binding motifs (UBM1 and UBM2) are found in the Y-family polymerase (Pol) 
ι, both of which contribute to ubiquitin-mediated accumulation of Pol ι during TLS. 
Although the Pol UBM2-ubiquitin complex has been previous reported by our lab and 
others, the Pol  UBM1-ubiquitin complex has remained a challenge due to significant 
signal overlap in conventional 3-D NOE spectroscopy. In order to determine the 
molecular basis for ubiquitin recognition of Pol ι, we solved the structures of human Pol 
ι UBM1 and its complex with ubiquitin by 4-D fast NMR, revealing a signature helix-
turn-helix motif that recognizes ubiquitin through an unconventional surface centered at 
L8 of ubiquitin. Importantly, the use of 4-D omit NOE spectroscopy unambiguously 
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revealed an augmented ubiquitin binding interface that encompasses the C-terminal tail 
of UBM1. 
4-D omit NOE spectroscopy was also used to study the Fanconi anemia 
associated protein 20 (FAAP20)-ubiquitin complex within the Fanconi Anemia (FA) 
complexes required for efficient repair of DNA interstrand crosslinks (ICLs), a process 
that is mediated by the ubiquitin-binding zinc finger (UBZ) domain of FAAP20. 
Unexpectedly, we show that the FAAP20-ubiquitin interaction extends beyond the 
compact UBZ module and is accompanied by transforming the disordered C-terminal 
tail of FAAP20 into a rigid -loop, with the invariant C-terminal tryptophan (W180 of 
human FAAP20) emanating toward I44 of ubiquitin for enhanced binding. Accordingly, 
alanine substitution of the absolutely conserved C-terminal tryptophan residue of 
FAAP20 abolishes ubiquitin binding and impairs FA core complex-mediated ICL repair 
in vivo. 
Reliable detection and unambiguous assignment of intermolecular NOEs is 
essential to NMR-based structure determination of protein complexes. The development 
of 4-D omit NOE spectroscopy in this thesis overcomes many limitations of conventional 
3-D half-filtered experiments to allow for reliable detection and unambiguous 
assignment of intermolecular NOEs of heterodimeric complexes and homooligomeric 
complexes. These advantages render such a strategy particularly attractive for structural 
studies of protein complexes by biomolecular NMR. 
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1. Introduction to structural study of protein complexes 
As the functional units within a living organism, proteins rarely act alone at both 
cellular and systemic levels. Instead, protein complexes carry out diverse essential 
molecular processes within a cell such as gene transcription, translation, signal 
transduction, cell growth, differentiation and immune response. Abnormal protein-
protein interactions that affect the formation and the function of normal protein 
complexes can lead to disease. In addition, proteins in eukaryotic cells are subject to 
various post-translational modifications such as phosphorylation, methylation, 
glycosylation and ubiquitination, which may further serve as signaling posts to recruit 
additional binding partners or to form higher order complexes, greatly enriching the 
diversity and functionality of protein complexes. Due to their essential roles in cellular 
function and disease, structural analyses of these protein complexes either by X-ray 
crystallography or NMR have not only shed important insights into the fundamental 
biology at the molecular level, but also provided important targets for disease 
intervention and developing novel therapeutics. 
1.1 Heterodimeric protein complexes 
A heterodimeric protein complex is the most common and simplest 
heteromultimeric protein complex. One interesting phenomenon of heterodimeric 
protein complexes is that the two proteins that need to bind to each other temporarily 
can be linked by interactions between a defined subdomain in one protein and a 
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chemical group that is transiently attached to the other. A classic example of this process 
is provided by protein domains that bind to phosphorylated amino acids, exemplified 
by the Src homology 2 (SH2) domain binding to tyrosine phosphorylated proteins (1). 
Ubiquitin is another type of post-translation modifier that labels proteins in a highly 
controlled matter (2). Ubiquitin recognition by ubiquitin-binding domains regulates a 
variety of biological events in the cell, including protein degradation, DNA repair, stress 
response and other events. 
1.1.1 Ubiquitination  
Ubiquitin, discovered in 1975, is a small protein with a highly-conserved 76 
amino acid sequence among eukaryotic organisms (3); yeast and human ubiquitin only 
differ by three residues. It is named for its extraordinarily ubiquitous distribution in 
cells from yeast to humans. Early interest in ubiquitination centered on the role of 
polyubiquitin chains in targeting proteins for degradation by the 26 S proteasome (4, 5). 
Accumulating studies have shown that ubiquitination regulates a much wider array of 
cell processes, including endocytosis, vesicular trafficking (6-8), cell-cycle control, stress 
response, DNA repair (9), signaling (10, 11), transcription and gene silencing.  
The three-dimensional structure of ubiquitin was first determined by X-ray 
crystallography in 1985 to reveal its  roll topology, now named as “ubiquitin fold” or  
“ubiquitin superfold”(12, 13). It contains a five-stranded β-sheet with a 3.5 turns α-helix 
on top, a short 310-helix and an exposed C-terminal tail with the last two glycine residues 
 3 
being flexible. Ubiquitin is a remarkably stable protein, and is resistant to changes in pH 
and temperature.  
Ubiquitination changes the molecular landscape of a protein, and can therefore 
influence the interactions of a protein with other proteins and, potentially, the three-
dimensional structure of a protein. In the “protein ubiquitination” process, the C-
terminus of free ubiquitin is activated by a ubiquitin activating enzyme (E1), passed on 
to a ubiquitin-conjugating enzyme (E2), and finally transferred onto an amino group 
with the aid of a ubiquitin ligase (E3) (14, 15). This results in the addition of a ubiquitin 
moiety to either the ε-amino group of a lysine residue or the extreme N-terminus of a 
polypeptide. Besides the modification of heterologous proteins, the targeted lysine can 
also reside within a second ubiquitin molecule, resulting in the formation of poly-
ubiquitin chains. There are very few E1 enzymes (only one in yeast and about ten in 
human), more E2 enzymes (11 in yeast and about 100 in human) and many E3 ligases (54 
in yeast and about 1000 in human), which determines the specificity of both the 
substrate and linkage type (16). Deubiquitylases (DUBs) reverse this modification by 
hydrolyzing the linkage between ubiquitin moieties or between ubiquitin and the 
substrate, rendering it a truly flexible signaling tag to regulate different cellular events 
(17, 18). 
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Figure 1: Structure of ubiquitin 
The structure of ubiquitin is shown in cartoon mode, colored in orange. The key 
residues, L8, I44 and V70, which forms the canonical hydrophobic patch for interacting 
with ubiquitin-binding domains (UBDs), are shown in the stick mode and colored in 
blue. Seven lysines from which can form polyubiuqitin chains are colored in red. PDB 
ID: 1UBQ 
 
 Ubiquitin contains seven conserved lysine residues (K6, K11, K27, K29, K33, 
K48, and K63), that are highlighted in Figure 1. Therefore, there are eight homotypic 
chains (a chain that comprises only one linkage type) and numerous branched or non-
branched heterotypic chains (a chain with two or more linkages). (Figure 2) These 
various types of ubiquitin chains further highlight the diversity of ubiquitination in 
different pathways.   
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Figure 2: Diversity of ubiquitination 
The ubiquitin molecule can be attached to a single site or multiple sites (A) on a 
substrate to yield mono- and multi-ubiquitination, respectively. (C) The ubiquitin 
sequence contains seven lysine residues that can support the assembly of polyubiquitin 
of different chain topologies, forming eight types of homotypical chains. Heterotypical 
polyubiquitination (B) occurs when a ubiquitin chain has alternating linkage types (non-
branched linkages) or when a single ubiquitin is extended at two or more lysine residues 
(branched linkages).  Adapted from (19). 
 
Different ubiquitin linkages have been shown to be involved in different 
pathways (20, 21). For example, monoubiquitination plays important roles in signaling 
pathways involving membrane protein trafficking and endocytosis (22, 23). Of the eight 
distinct linkage types, K48-linked and K63-linked polyubiquitin chains are the most 
thoroughly characterized, with K48-linked polyubiquitin acting as a targeting signal for 
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proteasomal degradation (24). Ubiquitination can also promote non-degradative 
outcomes. First identified in 1995, K63-linked ubiquitin chains are involved in cell 
signaling (e.g. NF-κB pathway) and are essential for the DNA damage response (25). 
Besides K48 and K63 linked chains, other less abundant types of ubiquitin chains may 
have their dedicated physiological role upon activation of their cognate assembly 
machinery under certain conditions (26). For example, the formation of linear ubiquitin 
chains (head to tail) by LUBAC (linear chain ubiquitin chain assembly complex) was 
recently discovered and is essential for the TNFα-stimulated NF-κB pathway (27-29). 
The abundance of the K11 linkage type, which is assembled by the APC/C (anaphase 
promoting complex, also known as the cyclosome) during mitosis, dramatically rises 
when cells exit mitosis. At this point, the APC/C becomes activated and acts as a 
proteasomal degradation signal in cell cycle regulation (30). Recent studies showed K27-
linked polyubiquitin plays dedicated roles in mitochondrial maintenance or mitophagy 
(31). Structurally, both K63- and linearly linked diubiquitin have similar extended 
conformations, with little or no contact between the ubiquitin moieties, whereas K48 
chains allow for the ubiquitin moieties to pack against each other (32). The formation of 
these various ubiquitin chains further expands the versatility of ubiquitin as a signal.  
1.1.2 Ubiquitin-binding domains (UBDs) and ubiquitin recognition  
Ubiquitin and the distinct conformations of the ubiquitin chains can serve as 
signaling components that trigger molecular events in cells. It does this by operating as a 
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reversible and highly regulatory signal for interacting with ubiquitin-binding domains 
(UBDs) in cellular proteins. Many molecular details of signal transmission from 
ubiquitinated proteins (substrates that are modified following various cellular stimuli) 
to effector proteins (ubiquitin receptors containing one or more UBDs) have been 
elucidated in the past decade (16, 32-34). 
Structures of ubiquitin bound to different UBDs indicate that ubiquitin adopts an 
overall similar conformation, with only slightly different structural changes of the loop 
connecting the secondary structural elements. An extensive set of residual dipolar 
couplings (RDCs) measured by NMR for analyzing the dynamic behavior of ubiquitin 
on the ps to s time scale in solution (35, 36) shows the bound ubiquitin structures 
correspond to an ensemble of structures sampled by free ubiquitin. This indicates that 
the ubiquitin inherently exhibits some degree of structural conformational 
heterogeneity, which contributes to the adaptive interface of ubiquitin in recognizing 
different UBDs. 
UBDs are usually very small (20-150 amino acids) protein modules that are 
diverse both in structure and in the mode of ubiquitin recognition. The binding affinity 
between ubiquitin and UBDs are typically in the range of M to mM. So far, more than 
twenty different families of UBDs have been identified, and the number is still growing 
(TABLE 1). Many of the families have at least one structural representative. Most of the 
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UBD-ubiquitin structures are UBD complexes with monoubiquitin, though structures of 
UBDs bound to linear, K48 or K63 linked diubiquitin are beginning to be elucidated (34).  
Even though the sizes, topologies, and structures of these UBDs vary, most of 
these domains interact with the solvent-exposed -sheet of ubiquitin, which contains a 
hydrophobic patch consisting of residues L8, I44, and V70 (Figure 1) and is surrounded 
by R42, K48, H68, and R72 (37, 38). Although ubiquitin has this canonical hydrophobic 
patch for protein-protein interaction, ubiquitin receptors utilize a variety of structural 
folds and unique binding modules for recognition of ubiquitin. The ubiquitin binding 
modules can generally be divided into four categories based on the fold: 1) α-helical 
structures, 2) zinc fingers (ZnFs), 3) ubiquitin conjugating (UBC) domains present in E2 
enzymes and 4) plekstrin homology (PH) folds. 
The largest class of ubiquitin-binding domains adopts -helical structures.  The 
UIM (ubiquitin interacting motif), which is found in many trafficking proteins that 
recognize ubiquitinated cargos and the S5a subunit of the proteasome, consists of a 
single α-helix that binds to the hydrophobic pocket of ubiquitin formed by residues L8, 
I44, and V70 (39, 40) (Figure 3A). UIM has two variants, MUIM/IUIM (motif interacting 
with ubiquitin/inverted UIM) of Rabex-5 (the Rab5 exchange factor) (41, 42) and the 
double-sided UIM (DUIM) of Hrs (hepatocyte growth factor-regulated tyrosine kinase 
substrate) (43). MIU binds to ubiquitin in a similar manner to UIM with the -helix in 
the inverted direction, whereas DUIM binds two ubiquitin molecules with equal affinity 
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using a short α-helix. In contrast, the UBA domain (ubiquitin-associated domain), the 
first UBD described, is a three-helix bundle in which two helices contact the canonical 
hydrophobic patch of ubiquitin (38, 44) (Figure 3F). The structure of the hHR23A UBA2 
domain in complex with K48-linked diubiquitin shows that the UBA domain is 
sandwiched in between two ubiquitin moieties. It uses either 1-3 or 2-3 to interact 
with the I44-centered hydrophobic patch of ubiquitin (45) (Figure 4A). Similar cases 
have been found for CUE (coupling of ubiquitin conjugation to endoplasmic reticulum 
degradation domain) (46)and GAT (Gga and Tom1) domains (47, 48). The UBAN 
(ubiquitin binding in ABIN and NEMO proteins) domain of NEMO is a parallel coiled-
coil dimer that binds to two linear ubiquitin chains (49, 50) (Figure 4C). Ubiquitin 
binding of the UBAN domain occurs to the canonical I44 surface of one ubiquitin moiety 
and with a surface adjacent to I44 on the second ubiquitin moiety. This structure 
highlights the fact that differences in the linker regions in polyubiquitin chains 
necessitate very specific interactions with UBDs. Another type of -helical UBD is UBM 
(ubiquitin-binding motif), which was identified in the translesion synthesis (TLS) 
pathways (51). It contains two -helices for interacting with ubiquitin. 
The second category of UBDs is zinc fingers (not to be confused with ubiquitin-
binding zinc finger or UBZ below), which does not bind to the canonical hydrophobic 
patch of ubiquitin (Figure 3C).  These domains recognize monoubiquitin by binding to 
three different regions on its surface. The nuclear protein localization 4 ZnF (NZF) 
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domain (52), which serves as a ubiquitin-binding adaptor protein in the endoplasmic 
reticulum-associated degradation (ERAD) pathway, consists of four strands that form a 
central set of “knuckles” through the coordination of four cysteine ligands to a central 
zinc ion. It binds to the hydrophobic surface of the ubiquitin -sheet centered on I44 and 
V70. By contrast, the A20-type ZnF domain of RABEX5 contacts a polar surface of 
ubiquitin that is centered on Asp58, whereas its C-terminal α-helical MIU/IUIM domain 
binds to the canonical I44 face (41, 42). A different binding surface is recognized by the 
DUB isopeptidase T (IsoT), the PAZ (polyubiquitin-associated zinc finger or the BUZ 
domain of Ubp-M, which consist of five β-strands and two α-helices, forming a deep 
pocket that binds to the C-terminal residues of ubiquitin (53, 54). UBZs (ubiquiting-
binding zinc fingers) are another type of UBD that contain a ββα classical zinc finger 
fold to interact with ubiquitin (49) and will be discussed in detail later. 
There are other types of UBDs with different fold and interaction modes with 
ubiquitin. The E2 ubiquitin-conjugating (Ubc) enzyme UbcH5c binds via its β-sheet with 
ubiquitin’s canonical hydrophobic surface (55) (Figure 3D). The GLUE (GRAM-like 
ubiquitin binding in EAP45) domain present in the EAP45 (ELL-associated protein of 45 
kDa) subunit of the complex ESCRT (endosomal sorting complexes required for 
transport) folds into a split PH domain using amino acids from a β-strand, loop, and α-
helix and associates with the hydrophobic surface of ubiquitin (56) (Figure 3E). The 
proteasomal receptor Rpn13 (Regulatory Particle, Non-ATPase-like 13) contains a PRU 
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(PH receptor for ubiquitin) domain that adopts a PH domain structure and uses loops to 
bind to the β-strand surface of ubiquitin (57) (Figure 3B). 
 
Figure 3: Structures of different types of UBDs in complex with monoubiquitin 
Ubiquitin is shown in grey, with I44 or D58 or C-terminal tails colored in blue, which are 
critical residues in the interface. (A) UIM (green) in complex with ubiquitin,  PDB ID: 
1YX5; (B) PRU (yellow) in complex with ubiquitin, PDB ID: 2Z59; (C) different types of 
zinc finger domains interact with different interfaces of ubiquitin, showing A20 type-
ZnF domain (orange) binding to D58 of ubiquitin, PDB ID: 2FIF, NZF domain (red) 
binding to I44 of ubiquitin, PDB ID: 1Q5W and BUZ domain (purple) binding to C-
terminal tail of ubiquitin, PDB ID: 2G45; (D) UBC (cyan) in complex with ubiquitin, PDB 
ID: 2FUH; (E) GLUE domain (lime) in complex with ubiquitin, PDB ID: 2DX5; (F) UBA 
domain (magenta) in complex with ubiquitin, PDB ID: 2JY6 
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Table 1: The functional and structural diversity of ubiquitin-binding domains 
UBD Representing proteins Functions References 
-helical 
UIM 
S5a/Rpn10, Vps27, 
STAM, epsins, 
Rap80(UIMC1) 
Proteasomal degradation, 
endocytosis, MVB biogenesis, 
DNA repair 
(40, 58-60) 
MIU(IUIM) Rabex-5 endocytosis (41, 42) 
DUIM HRS MVB biogenesis (43) 
UBA 
Rad23/hHR23A, NBR1, 
Ede1, p62, Dsk2 
Proteasome targeting, kinase 
regulation, autophagy, 
endocytosis 
(44, 61, 62) 
UBAN 
NEMO, ABIN1-3, 
optinurin 
NF-B signaling, linear 
ubiquitination 
(49, 50) 
UBM Pol , Rev1 DNA damage tolerance (63, 64) 
GAT GGA, TOM1 MVB biogenesis (47) 
CUE Vps9, TAB2, TAB3 Endocytosis, kinase regulation (46, 65) 
VHS STAM, GGA3 MVB biogenesis (66) 
Zinc finger 
UBZ 
Pol , Pol , NEMO, 
Rad18, WRNIP, Tax1BP1 
DNA damage tolerance, NF-B 
signaling 
(67-69) 
NZF 
Npl4, Vps36, TAB2, 
TAB3 
ERAD, MVB biogenesis, kinase 
regulation 
(52) 
BUZ/ZnF-
UBP/PAZ 
IsoT, HDAC6, Ubp-M 
Polyubiquitin chain 
disassembly, autophagy 
(53, 54) 
ZnF A20 Rabex-5 and A20 Endocytosis, kinase regulation (41) 
UBC-like 
UEV Uev1, Mms2 
DNA repair, MVB biogenesis 
and kinase regulation 
(70, 71) 
Ubc UbcH5C ubiquitination (55) 
PH domain 
PRU Rpn13 Proteasome function (57) 
GLUE Eap45 (VPS36) MVB biogenesis (56, 72) 
Other 
SH3 Sla1, CIN85 Endocytosis (73-76) 
PFU Doa1/Ufd3 ERAD (77) 
Jab1/MPN Prp8 RNA splicing (78) 
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Ubiquitin signaling appears to play a particularly prominent role in the DNA 
repair signaling pathways, including translesion synthesis (TLS) and repair of DNA 
interstrand crosslinks (ICLs).  The ubiquitin-binding motif (UBM), which belongs to the 
-helical family of UBDs and Ubiquitin-binding zinc finger (UBZ), which belongs to the 
zinc finger family of UBDs, are two typical kinds of UBDs that are dedicated to DNA 
damage response pathways (51, 79). The UBM domain, for example, has been shown to 
recognize ubiquitin through a non-canonical interface centered at L8 instead of I44. 
Previous studies from our lab and others have characterized the ubiquitin interaction of 
the C-terminal UBM (UBM2) of human translesion polymerase  (64) and the UBZ of 
translesion polymerase  However, the N-terminal UBM (UBM1) of polymerase  
displays significant sequence variation from UBM2, including the residues of the 
ubiquitin binding interface of UBM2, and hence requires further structural and 
biochemical investigations. Recent bioinformatics studies have also revealed distinct 
subfamilies of the -UBZ fingers that are predicted to interact with ubiquitin using 
binding modes distinct from the well characterized UBZ3 subfamily represented by the 
UBZ of polymerase demanding further structural analysis of UBZs from other 
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subfamilies (79). 
 
Figure 4: UBDs interacts with di-ubiquitin with different linkages 
Multivalent interactions between ubiquitin and UBDs define chain specificity and 
increase affinity. Proximal ubiquitins are colored in red, distal ubiquitins are colored in 
orange, I44 are shown in stick mode and colored in purple. K48 or K63 are colored in 
green. (A)The UBA2 domain (blue) of RAD23A, is sandwiched between the two 
ubiquitin moieties of K48-linked diubiquitin, (PDB ID: 1ZO6) for expanding its binding 
surface beyond that possible for monoubiquitin. (B) Structure of K63-linked diubiquitin 
bound to RAP80, (PDB ID: 2RR9) showing its contiguous helix binds simultaneously to 
two ubiquitin moieties in the extended conformation for increasing its affinity. (C) The 
UBAN domain in NEMO forms a coiled coil, which binds two linear diubiquitins. (PDB 
ID: 2ZV0). Extensive contacts are formed with both ubiquitin moieties, thus conveying 
specificity for linear ubiquitin chains.  
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1.2 Homooligomeric protein complexes 
Homooligomeric complexes are ones in which the interacting subunits are 
identical proteins. The majority of cellular proteins exist as symmetric oligomers with 
distinct biochemical and biophysical properties, which often provide the means for 
additional regulation of their function at the post-translational level (80-82). 
Homooligomers are found in enzymes, carrier proteins, scaffolding proteins and 
transcriptional regulatory factors. For example, E. coli diacylglycerol kinase (DAGK), a 
homotrimer, represents a family of integral membrane enzymes that is unrelated to all 
other phosphotransferases and is an important therapeutic target (83); Atm1-type (ATP)-
binding cassette (ABC) transporters, a homodimer, plays an important role in the 
cellular detoxification processes (84, 85); D13, a homotrimer, is the scaffolding protein of 
vaccinia virus (86) and is the target of rifampicin. The famous tumor suppressor p53 also 
functions as homooligomer (87) through its tetramerization domain. Despite the 
essential biological function of homooligomer proteins, their structural analysis by 
solution NMR is particularly challenging due to the data interpretation ambiguity 
caused by the symmetry of the homooligomeric protein. Such challenges are highlighted 
by the structural discrepancy of the solution and crystal structures of DAGK, an integral 
homotrimeric membrane protein. The solution structure of DAGK, solved in DPC 
micelles, shows an atypical domain-swapping feature (88) (Figure 5A), whereas the 
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crystal structure (89) illustrates a different fold of the monomer itself, and the packing of 
the trimer does not involve domain-swapping (Figure 5B).  
 
Figure 5: Comparison of NMR and crystal structure of DAGK 
DAGK homotrimer shows completely different conformations as determined by NMR 
(A) (PDB ID: 2KDC) and crystal structure (B) (PDB ID: 4UP6).  
 
The structural discrepancy of DAGK highlights the challenge of the structural 
analysis of protein complexes by solution NMR and encourages the development of new 
techniques to improve the reliability of the structural analysis of macromolecular 
assemblies. In this thesis, I outline the development of high-resolution 4-D omit NOE 
spectroscopy for structure determination of protein complexes. Such an approach has 
been applied to structural analyses of the homotrimeric foldon complex, the 
heterodimeric ubiquitin-Pol  UBM1 complex and the ubiquitin-FAAP20 UBZ complex.  
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2. Development of 4-D omit spectroscopy for 
measurements of intermolecular NOEs 
2.1 NMR studies of protein complexes 
NMR remains as the only method for high-resolution structural elucidation of 
protein complexes in solution. It also readily reveals dynamic information that may not 
be accessible by crystallography. Recent pioneering work by Kay and co-workers have 
also demonstrated the feasibility of NMR to probe the structure and dynamics of minor 
populated high-energy states (90), opening up new frontiers for studies of transiently 
accessible conformational states of macromolecules and their complexes. 
Traditional NMR structural analysis has relied on the measurements of Nuclear 
Overhauser Effect (NOE), the enhancement of one spin signal due to magnetization 
transfer from another dipolar coupled spin system through cross-relaxation. Commonly 
used NOE experiments include 3-D 15N-NOESY that detects the NOEs towards amide 
protons and 3-D 13C-NOESY that detects the NOEs towards 13C-attached protons. Since 
the strengths of the NOE signals are inversely proportional to the distance (r-6) of two 
interacting spins, they provide spatial restraints for NMR structural calculations. In 
addition to calculating an ensemble of NMR structures, quantitative analysis of NOEs 
can also reveal correlated motions within the structural ensemble (91). 
Distance information provided by 1H-1H NOE crosspeaks with state-of-the-art 
spectrometers equipped with cold probes are typically restricted to 6 Å  in fully 
protonated protein samples, though NOEs involving protons 10-15 Å  apart have been 
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reported for deuterated proteins with selective methyl labeling. The NOE-derived 
distance information can be complemented with measurements of Paramagnetic 
Relaxation Enhancement (PRE). The large magnetic dipolar interaction of the unpaired 
electron from a paramagnetic atom with the neighboring NMR-active nucleus results in 
an increase of the relaxation rate of the nucleus (92). Similar to NOE, the PRE effect has 
the basic r-6 distance proportionality, but, because of the larger magnetic moment of the 
electron, the PRE effect is observable at longer distances, up to 25–35Å , distances 
depending upon the nature of the particular paramagnetic group (93, 94). Stable 
nitroxide radicals (eg. MTSL) (95) and metal chelators, such as EDTA-Mn2+, that are 
characterized by an unpaired electron with an isotropic g-tensor, are especially useful 
for measuring the PRE effects. 
Residual dipolar couplings (RDCs) are another set of commonly used NMR 
constraints for structural analysis. The physical basis of RDCs is the dipole-dipole (DD) 
interaction between two nuclear spins. In an isotropic environment, the dipolar coupling 
cancels out due to the free tumbling of the protein molecule. In a solution with partial 
alignment, an incomplete averaging of spatially anisotropic dipolar couplings results in 
the residual dipolar coupling (RDC) between two spins in a protein molecule, which is 
in the range that can be measured spectroscopically (typically 10-50 Hz). RDCs give the 
orientation information of each chemical bond relative to the external magnetic field B0. 
Therefore, it provides global orientational constraints for NMR structure determination 
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or refinement. It is a useful tool that complements the NOE constraints and is 
particularly useful for measuring the bending of a long -helix, for determining the 
orientation of two interacting protein domains, and for deciphering subunit orientations 
in a homooligomer system. 
Dipolar coupling manifests itself as an additional coupling to the J-coupling. 
RDC measurements normally require two NMR samples prepared in parallel, one with 
the presence of an aligning medium and the other without, corresponding to anisotropic 
and isotropic conditions, respectively. Measurement in the isotropic medium yields J, 
while measurement in the anisotropic medium yields J +D (96), and the difference yields 
the dipolar coupling D. The commonly measured Ds are DH-N, DH-C and DC-CO (97, 98). 
In order to measure RDC, a partially aligned media is needed for sample 
preparation. Common alignment media include liquid crystalline media(99), bicelles 
made of dimyristoylphosphatidylcholine (DMPC) and dihex-anoylphosphatidylcholine 
(DHPC) (100), filamentous phages Pf1 (101) and stretched or compressed 
polyacrylamide gel (102-104) and DNA based media (105). Addition of charged 
molecules into the alignment media has been shown to generate different alignment 
tensors for protein molecules (106). This is a particularly useful property as one type of 
alignment media is usually sufficient for structural refinement, whereas for de novo 
structure determination, any additional orthogonal alignment tensors from a new 
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alignment media add new information to better define bond vector orientation and 
dynamics. 
In comparison with the long range information provided by NOEs, PREs and 
RDCs, measurements of vicinal scalar coupling between HN and Ha can provide 
dihedral angle constraints for determining the backbone dihedral angles  and ψ (107). 
Similar information can also be extracted through analysis of chemical shifts of backbone 
atoms, which has been shown to correlate with the dihedral angles of the peptide bonds 
(108). 
Despite the successful application of these aforementioned methods for 
structural analysis by NMR, there are limitations in particular with regard to the 
structural analysis of protein complexes. For the RDC methods, finding a suitable 
alignment media that is compatible with the target protein complex can be a challenge. 
Additionally, distinct sets of RDCs (e.g., both 1DHN and 1DHC) measured with sufficient 
precision are required for de novo structure determination (109), which may be 
challenging for protein complexes beyond 15 kDa. Although measurements of PREs 
have provided long-range distance information, they are typically not as accurate as 
NOE-derived distances due to the intrinsic flexibility of either the paramagnetic tag itself 
or the flexible linker that it uses to attach to the protein. Such flexibility results in the 
time-averaged distances sampled over all possible conformations. Although PRE-
derived long range constraints are most useful for defining the global fold of a target 
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protein, they are much less informative for defining interface interactions (110). 
Therefore, accurate measurements and analyses of intermolecular NOEs have become 
critical for structural analyses of protein complexes.  
2.2 Current techniques for detection and assignment of 
intermolecular NOEs of protein complexes 
Detection of intermolecular NOEs is traditionally achieved by half-filtered 
experiments (111, 112). The general strategy involves (1) isotopic labeling of a subset of 
the signals (usually a component of the protein complex) and (2) spectroscopic 
suppression of protons attached to 13C or 15N nuclei prior to NOE transfer followed by 
selective detection of 13C or 15N-attached protons for signal observation. Theoretically, 
this approach selectively detects dipolar interactions from protons in the unlabeled 
component to protons in the isotopically-labeled component within the same protein 
complex, thus ensuring all of the observed NOE crosspeaks are intermolecular. 
However, the large variation of 1JHC couplings from the methyl groups (~125 Hz) to 
aromatic groups (~200 Hz) makes it extremely difficult to achieve perfect suppression of 
isotope-attached proton signals. Thus, two solutions have been proposed to improve the 
robustness of half-filtered experiments. 
The first approach is to incorporate adiabatic frequency swept carbon inversion 
pulses presented by Zwahlen et al. (113) The concept is based on the empirical 
relationship between 1JHC coupling constants with the isotropic 13C chemical shifts, which 
is an approximately linear relationship for both proteins (Figure 6) and RNA. A filter 
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element can then be designed in which the conventional 13C inversion pulse is replaced 
by a pulse whose frequency is swept adiabatically during the filter delay, such that 
inversion of 13C spins occurs at a time that is a function of both offset and the value of 
1JHC couplings. Therefore, the effective INEPT transfer times can match with the 
variation of 1JHC couplings. 
 
Figure 6: Correlation between 1JHC and 13C chemical shift in proteins. 
The equation for the line derived from linear regression analysis is: 1JHC = (0.365 ±0.010 
Hz/ppm) C + 120.0 ± 0.5 Hz.  Adapted from Zwahlen et al. (113) 
 
The second approach is based on the isomorphism between broadband 
polarization transfer and composite pulse rotations (114). Composite pulses 
compensated for B1 inhomogeneity are converted to sequence elements compensated for 
variation in 1JHC couplings. In addition, the entire filter period can be used for frequency 
labeling in a semiconstant time manner (115) to provide increased resolution in the 
indirect 1H evolution dimension of 3-D half-filtered NOESY experiment. Also, since the 
filter efficiency does not depend on empirical correlations between 13C chemical shifts 
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and 1JCH coupling, this approach will be useful for performing isotope-filtered 
experiments in weakly aligned systems for which RDC contributes to the apparent 
coupling interaction (116). 
The performance of the isotope filter can be further enhanced by a combination 
of both approaches to generate joint composite-rotation adiabatic-sweep isotope filter 
sequences, or low pass J-filters (117). Combination of the two approaches yields much 
better filtration efficiency, compared with methods individually, particularly for 1H 
spins with coupling constants that are near the extreme of the range of values or that do 
not satisfy empirical relationships between isotropic chemical shifts and scalar coupling 
constants. 
Despite these elegant solutions, it is still challenging to achieve ideal suppression 
of intramolecular NOE crosspeaks. In publications that applied 3-D half-filtered NOESY 
experiments for detecting and assigning intermolecular NOEs for complex structure 
determination, the insufficiently suppressed intramolecular NOE peaks are usually 
labelled with a cross (Figure 7). This trend has remained constant in the NMR field for 
almost two decades. Even in very recent publications (118), cross-labelled artifactual 
peaks still exist in the spectrum, which complicates data analysis (Figure 7).  
Additionally, since the protein-protein interface often consists of similar functional 
groups (e.g., methyl-methyl packing) that share similar proton chemical shifts, these 
intermolecular NOE crosspeaks are often located very close to the diagonal positions. 
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Thus, incompletely suppressed diagonal signals, which are significantly stronger than 
the NOE crosspeaks, often cause assignment uncertainties. Furthermore, a lack of 
chemical shift dispersion in the proton dimensions suggests that even if the 
intramolecular NOEs can be suppressed with confidence, proton chemical shift 
degeneracy can still cause assignment ambiguities, precluding reliable assignment of all 
interfacial NOEs.  
 
Figure 7: Examples of 3-D half-filtered NOE spectra 
Figures adapted from current literature (left: (119); right (118)) showing 3-D half-filtered 
NOE spectra. Peaks labeled with crosses are boxed in red, which are explained as 
insufficient suppression of intramolecular NOEs.  
 
The presence of significant levels of spectral artifacts in the 3D half-filtered NOE 
experiments coupled with assignment ambiguity may also lead to the determination of 
distorted or erroneously packed protein complexes. An example illustrating the 
limitation of 3-D half-filtered NOESY experiments is the solution structure of the 
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oligomerization domain of p53(120), which forms a dimer of a dimer. Each monomer 
consists of an -helix and a -strand. The -strand from each monomer becomes 
antiparallel to form a dimer; while the dimer packs with another dimer through helical-
packing. Compared with the 1.7Å  crystal structure solved later on (121), the dimer-
dimer interface in the solution structure is twisted (compare Figure 8A and B). After 
reanalyzing the NMR data, the authors found three mis-assigned intermolecular NOEs 
that should be spectrum artifacts and most importantly, three real intermolecular NOEs 
from the 3-D half-filtered NOESY experiment that were missed because they were 
treated as insufficient suppression of the intramolecular NOEs (Figure 8D) (122). One of 
the missed intermolecular NOEs, which was between two neighboring residues K351 
and L350, was particularly strong. Due to the possible existence of residual 
intramolecular NOEs, it was conservatively assigned to be intramolecular. It turned out 
to be a key intermolecular NOE which correctly defined the dimer-dimer interface. After 
correction of the mistakes, the recalculated NMR structure overlaid very well with the 
crystal structure (compare Figure 8B and C). 
 26 
 
Figure 8: Structural study of oligomerization domain of p53 
(A) Original solution NMR structure with tilted dimer-dimer interface; (B) crystal 
structure ; (C) corrected solution NMR structure; (D) Portion of the 3D 13C-
edited(F2)/12C-filtered(F3) NOE spectrum (120 ms mixing time) of the oligomerization 
domain of p53 comprising a 1:1 mixture of unlabeled and 13C/15 N-labeled polypeptide, 
specifically illustrating inter-subunit NOEs involving the methyl protons of Leu350. Real 
intermolecular NOEs peaks that were misassigned to be insufficient suppression are 
boxed in red. Adapted from Clore, M.G. et. al. (122). 
 
These examples illustrate the limitations of current NMR methodology. In order 
to develop a robust method for structural analysis of protein complexes, we have 
developed 4-D omit NOE spectroscopy based on fast NMR technology and difference 
NOE spectroscopy. 
2.3 Fast NMR 
NMR experiments are traditionally limited by sensitivity, but advances in pulse 
sequence design (123) and instrumentation development, including higher field magnets 
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and cryogenically-cooled probes, have both boosted the sensitivity of NMR experiments 
(124). Because of these advancements, NMR has changed from a sensitivity-limited 
technique to a spectral resolution and dimensionality-limited technique. As an example, 
high-dimensional NMR experiments are extremely useful for better signal separation 
and more reliable data analysis. However, these high-dimensional NMR experiments 
are constrained by the long experimental measurement times. The development of fast 
NMR, which uses sparse sampling to dramatically reduce experimental measurement 
times, has becomes essential for the next generation of NMR experiments (125).  
Conventional sampling of NMR experiments uses the Nyquist interval to create a 
regular grid of sampling points in the time domain (Figure 9A). It systemically increases 
the chemical shift evolution period of each indirectly-encoded nucleus by a fixed 
amount of time. The Nyquist interval in each dimension is determined by the spectral 
width, and represents the lowest sampling rate required to unambiguously define the 
frequencies of the signals recorded in that dimension. Therefore, conventional sampling 
prescribes the minimum pattern needed to uniquely determine the position of peaks in 
multidimensional NMR spectra. However, a fundamental limitation of conventional 
sampling is that the number of sampling points grows exponentially as the 
dimensionality of experiments increases. For example, a 3-D experiment collected with 
64-point resolution in each indirect dimension requires 642 (4,096) sampling points, 
which typically translates into ~36 hours of acquisition time, whereas a 4-D experiment 
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collected with 64-point resolution in each indirect dimension requires 643 (262,144) 
sampling points, which requires ~194 days for data acquisition. Such an unrealistically 
long acquisition time hinders the application of high-resolution 4-D experiments. 
 
Figure 9: Fourier transform of sparse sampled data 
The distribution of points that are being sampled in the time domain is shown for 
different sampling patterns in the upper panels. (A) is conventional Nyquist sampling, 
(B) is radial sampling, (C) is concentric ring sampling, (D) is random sampling and (E) 
low resolution Nyquist sampling. Axes represent indirect dimensions. Lower panels 
show the corresponding Fourier transform results for each sampling pattern. Adapted 
from Coggins et al. (126) 
 
In order to speed up the acquisition of higher-dimensionality experiments, 
sparse sampling was developed, which uses a smaller number of points than required 
by conventional Nyquist sampling, thereby reducing the acquisition time. One of the 
first sparse sampling patterns introduced in the NMR field for 3-D experiments was 
radial sampling (Figure 9B). Such sampling places points in the time domain along 
radial spokes that meet at the origin (127). It is like sampling the time domain in the 
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polar coordinates instead of the Cartesian coordinates (128-130).  The realization of 
radial sampling as a form of sampling in the polar coordinate has led to the use of 
discrete FT to process sparsely sampled NMR data and the interpretation of the 
associated “noises” being the aliasing artifacts (128, 131-133). 
Besides radial sampling, there are a number of other sampling patterns including 
concentric ring or shell sampling (Figure 9C), random sampling (Figure 9D), and spiral 
sampling (134, 135). The distribution of sampling points on these patterns is usually 
weighted using an exponential or cosine function, biasing the measurement of low-
resolution information found close to the origin of the time domain, in order to improve 
sensitivity and to impart a lineshape in the frequency domain.  
These sparse sampling methods reduce the number of experimental 
measurements, which dramatically decrease the acquisition time of high-dimensionality 
spectra. The exact amount of time savings depends on the number of points sampled. 
The lower boundary of the sampling points depends on a variety of factors, but it should 
not be lower than the number of signals to detect. In reality, with ~1% of the sampling 
points, 4-D NOESY data can be successfully collected for protein around 30kDa within 4 
days to identify a sufficient number of NOEs for structure determination.  
Even though sparse sampling saves data acquisition time, this benefit comes at 
the cost of introducing aliasing artifacts. As described above, conventional sampling 
utilizes the minimum number of measurements required to precisely define the 
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frequencies of observed signals. Sparse sampling purposely uses numbers less than 
minimum which creates uncertainty in the frequency measurement of each signal, 
generating aliasing artifacts in the spectrum. There are several properties of aliasing 
artifacts: 1) the form of aliasing artifacts depends on the sampling pattern; 2) the 
intensity of aliasing artifacts depends on the extent of undersampling; 3) the level of 
artifacts generated by each signal is proportional to the signal’s intensity. The third 
property is particularly problematic for spectra with high dynamic range, like NOESY 
spectra. The important NOE crosspeaks will be covered by the aliasing artifacts brought 
with strong diagonal signals.  
To solve this problem, it is necessary to employ algorithms that remove aliasing 
artifacts as part of spectral processing following data collection. This can be realized 
because aliasing artifacts generated by a given peak can be predicted from the peak’s 
intensity and spectral position and the sampling pattern. Following FT computation of 
the sparsely-sampled spectrum, the most intense peak is identified, and its artifact 
pattern is calculated based on the parameters described above. The peak and its artifacts 
are then subtracted from the spectrum, often revealing weaker peaks that were masked 
by the artifact noise. This process can be repeated iteratively until some stopping 
criteria, usually based on the residual noise level or the ability to confidently identify 
more peaks for processing, is reached. Uncorrupted peaks are then added back to yield a 
spectrum with reduced artifact levels (Figure 10).  
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Figure 10: Removal of aliasing artifacts by CLEAN 
Sparse sampling introduces aliasing artifacts after FT computation (A), from which the 
tallest peak is identified and its artifact pattern is calculated (B). The “Component” built 
from tallest peak in the starting spectrum (B) is subtracted from the starting spectrum 
(A) to generate (C), from which the second component is identified and built (D). This 
process can be repeated iteratively (E to I) to the basal residual noise level. Uncorrupted 
peaks are then added back to yield a final “CLEANed” spectrum with reduced artifact 
levels (J). 
 
One algorithm following this concept is called CLEAN (134), which has been 
successfully applied to scalar coupling based backbone and sidechain resonance 
experiments, such as 4-D HCCH-TOCSY experiments (134). Such an approach can be 
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particularly beneficial in triple-resonance backbone experiments for sequential 
assignment of 15N/13C double labeled proteins (136). These triple resonance experiments 
utilize the relatively large magnetic couplings of the 1JNH, 1JCH, 1JCC, and 1JCN to establish 
the scalar connectivity pathway between H, C, C and CO atoms of neighboring 
residues. Conventional four pairs of triple-resonance experiments typically take over a 
week to collect, whereas implementation of the sampling technique (with 5% sampling 
density) followed by CLEAN reconstruction reduces the data acquisition time of the 
corresponding four pairs of 3-D triple resonance experiments—CA pair (HNCA and 
HN(CO)CA), CB pair (HN(CA)CB and HN(COCA)CB), CO pair (HNCO and 
HN(CA)CO) and HA pair (HA(CA)NH and HA(CACO)NH)—down to less than one 
day.  
The ability to remove aliasing artifacts by CLEAN is not sufficient for use in the 
most challenging cases, such as NOESY spectra with diagonal signals. This is because 
the fractional subtraction of peaks by CLEAN can only allow each peak to be reduced 
down to the level of the apparent noise, at which point the residual signal can no longer 
be confidently distinguished. Thus, CLEAN leaves behind “stumps” for each peak at the 
level of apparent noise, along with the artifacts generated by the residual intensity. To 
solve this problem, a new algorithm called SCRUB (Scrupulous CLEANing to Remove 
Unwanted Baseline Artifacts) was developed (107) (Figure 11). SCRUB utilizes the basic 
CLEAN concept for removing artifacts, but is designed to process peaks in batches, 
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beginning with those that are strongest and well above the noise level, and applies 
special criteria to identify and include points adjacent to each peak’s center, so that the 
full peak shape is subtracted rather than only the strongest point. In a simulated 
comparison, SCRUB reduces aliasing artifacts 250-fold further than CLEAN, making it 
well-suited for the reconstruction of sparsely sampled NOESY experiments. Indeed, 
exceptionally high-quality reconstruction of time-shared amide-methyl 4-D NOESY 
experiments has been achieved using SCRUB (107). 
 
Figure 11: Comparison of DFT, CLEAN and SCRUB 
Compared with DFT (left panel) and CLEAN (middle panel), SCRUB (right panel) has 
much higher dynamic range. 
 
2.4 Development of 4-D omit spectra for detection and 
assignment of intermolecular NOEs of protein complexes 
The improvement in sensitivity brought by the advancement of NMR 
instrumentation and the development of fast NMR technology with a high-quality 
reconstruction algorithm such as SCRUB has opened an exciting opportunity to develop 
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and apply novel experiments for studies of protein complexes. This is particularly 
important for NMR structural analysis of protein complexes, as the limited number of 
intermolecular NOEs that define the interface between the individual components in the 
macromolecular complexes require reliable detection and unambiguous assignment to 
ensure the proper assembly of the protein complex, which cannot be fulfilled with 
conventional 3-D half-filtered NOESY experiments as commented on previously. 
In order to overcome the limitations of the conventional 3-D half-filtered NOESY 
experiment for detection of intermolecular NOEs, we developed a sparsely-sampled 
high-resolution 4-D 13C HMQC-NOESY-HSQC experiment (Figure 12) to selectively 
detect NOEs from 13C-attached proton to 13C-attached proton.  
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Figure 12: Pulse sequence for the 4-D 13C HMQC-NOESY-HSQC experiment. 
Narrow and wide bars represent 90° and 180° pulses, respectively. All pulses are applied 
along the x-axis unless noted otherwise. Adiabatic broadband 13C inversion pulses (500 
s) are used as previously described during INEPT transfer (113). Selective sinc-shaped 
13CO pulses are applied at 175 ppm with a null excitation at 56 ppm. An empirically 
optimized phase shift of =13° is applied to the 90° 13C pulses after t1 and t3 to 
compensate Bloch-Siegert effects. A modified HMQC element was employed in the first 
two dimensions (F1-F2) to reduce signal relaxation based on the multi-quantum effect 
(137), whereas utilization of the HSQC element in the F3-F4 dimensions allows better 
water suppression using gradients. A semi-constant time evolution scheme is employed 
on both sides of the 13C evolution periods in the HMQC element for recording 1H 
chemical evolution and building the 1H-13C correlation. A shortened initial delay of 
tauCH1=1.6 ms is employed to reduce signal relaxation during the INEPT 1H-13C transfer 
step. The duration of the active 1JHC coupling period is allowed to grow to tauCH3=2.1 
ms when the proton evolution time permits. This modification enhances the sensitivity 
of the experiment for large proteins, but does not affect the quality of the signal 
selection. It should be noted that such an approach cannot be used in half-filtered 
experiments as in order to achieve ideal suppression of isotope-attached proton signals, 
a full delay is required for optimal buildup of 1JHC correlations and subsequent 
suppression in the half-filtered experiment. The delays are t2a=tauCH1-*t2/4, t2b=(1--
)*t2/4, t2c=tauCH1+*t2/4, t2d=t2/4, mix=200 ms, 2=1.8 ms. =tauCH1*4/t2max (for <1) 
or =1. =(tauCH3-tauCH1)*4/t2max (for < 1-) or =1-. 1H and 13C carrier frequencies 
are set to 4.8 ppm and 67 ppm, respectively. Carbon decoupling during acquisition is 
achieved by using a wurst40 sequence covering a bandwidth of 160 ppm (32.18 kHz on 
an 800 MHz spectrometer). Phase cycling is 1=[x,-x], 2=[x], 3=[x,x,-x,-x], rec=[x,-x,-x, 
x]. Gradient durations and field strengths are G1 = (1 ms, 15.72 G/cm), G3 = (3.88 G/cm), 
G4 = (1 ms, 19.80 G/cm), G5 = (1 ms, 18.58 G/cm), G6 = (0.5 ms, 12.86 G/cm), G7 = (1 ms, 
20.21 G/cm), G8 = (0.5 ms, 12.45 G/cm). Quadrature detections in F1, F2, and F3 are 
achieved using the States-TPPI method by changing 1,2, and 3, respectively. 
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In addition to the ability to separate degenerate proton signals, a key feature of 
such a 4-D experiment is that it selectively detects NOEs between protons attached to 13C 
nuclei. Hence, by subtracting NOE signals of subunit-selectively labeled protein 
complexes from the uniformly labeled protein complexes (Figure 13), one generates an 
“omit” spectrum–a concept analogous to the omit electron density map in 
crystallography (138) and the 2-D double difference NOE spectroscopy employing 
selective protein deuteration (139) – that only contains intermolecular NOE crosspeaks 
for unbiased data interpretation. Although such an approach is conceptually simple, it 
can only be achieved with a high-resolution 4-D NOESY experiment, but not with a 3-D 
NOESY-HSQC experiment, as the latter does not allow for selective detection of NOEs 
within isotopically-enriched subunits. Therefore, its application in biomolecular NMR 
has been prohibited by the lengthy data acquisition times of conventional high-
resolution 4-D experiments (typically many weeks). The development of sparse 
sampling techniques (127, 140) and robust reconstruction algorithms overcomes this 
obstacle by making it practical to collect high-resolution 4-D NOESY spectra using only 
a fraction of the measurement time compared to the conventional approach. Although 
sparse sampling introduces aliasing artifacts proportional to the intensity and square 
root of the number of the NMR signals, these artifacts can be suppressed using iterative 
reconstruction algorithms such as SCRUB (141). As an added benefit, by subtracting NOE 
signals of individually labeled components from the uniformly labeled protein complex 
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in the time domain, one not only removes the very strong diagonal signals, but also 
drastically reduces the number of NOE signals for reconstruction, both of which further 
enhance the quality of the reconstructed omit spectrum containing intermolecular 
NOEs. In order to make sure all the peaks in the 4-D omit NOE spectrum are 
intermolecular NOEs, the peak intensity of all the diagonal peaks from the uniform-
labeled and subunit-labeled spectra are measured so that scaling factors for subtraction 
can be calculated to make sure the intensity of all the intramolecular NOEs are either 
below noise level or negative. In most cases, this slight over-subtraction will not affect 
the intensity of the intermolecular NOEs except in situations in which there is an 
intramolecular NOE peak that completely or partially overlaps with the intermolecular 
NOE peak.  
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Figure 13: Concept of 4-D omit spectrum 
Blue and red rectangles represent two interacting moieties in a heterodimeric protein 
complex. Yellow areas represent the interface. Circles represent protons, while dash 
lines represent the NOEs between protons. Colored portions denote isotopically-labeled 
and detected parts, while grey portions denote non-isotopically-labeled and undetected 
parts.  
 
Compared with conventional 3-D 13C half-filtered NOESY-HSQC experiments, 
there is little loss of sensitivity in a high-resolution 4-D 13C HMQC-NOESY-HSQC 
experiment, as both experiments require similar durations of active J-coupling periods 
for building up H-C correlations, either for isotope signal suppression (as in half-filtered 
experiments) or for signal selection (as in the 4-D 13C HMQC-NOESY-HSQC 
experiment). On the other hand, 4-D NOE spectroscopy offers much better signal 
separation than a 3-D half-filtered NOESY-HSQC experiment because of the extra C 
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dimension. Each peak is now identified from two pieces of chemical shift information: 
proton chemical shift and the directly-attached C chemical shift, which greatly reduces 
the assignment ambiguity. Additionally, because a 4-D 13C HMQC-NOESY-HSQC 
experiment naturally selects intramolecular NOEs within the isotopically-labeled 
component of a protein complex, and because clean selection of isotope-attached proton 
signals is much easier to achieve than perfect suppression of the same signals, 4-D 
NOESY is much less affected by the variation of 1JHC couplings, thus ensuring the quality 
of intramolecular NOE spectra. Therefore, data analysis of 4-D omit spectra is much 
simpler and more reliable than analyzing 3-D half-filtered NOESY spectra.  
As a proof-of-concept study, we applied this technique to the structural analysis 
of the T4 bacteriophage foldon trimeric domain. 
2.5 Foldon 
Bacteriophage T4 is a bacterial virus that consists of a prolate head, which 
contains DNA, and a six fold-symmetric tail, which is used for extruding viral DNA 
during infection. Fibritin is a 52 kDa protein product of the late gene wac (whisker 
antigen control) of phage T4. After the phage head is joined to a fiberless tail, six fibritin 
molecules attach to the “neck” of the virion through its N-terminal domain to form the 
collar structures (“whiskers”). Fibritin promotes the virus assembly, controls the 
retraction of the long tail fibers and is also the major component of the collar-whisker 
complex. Fibritin consists of an N-terminal anchor domain (residues 1-46), a large 
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central coiled-coil portion (residues 47-456), and a small C-terminal globular domain 
(residues 457-486) (142).  
The thirty amino acid residue C-terminal domain is called foldon because of its 
essential function of fibritin trimerization and folding in vivo and in vitro (143, 144). The 
foldon domain is a trimeric -sheet propeller consisting of monomeric -hairpin 
segments. The trimer is stabilized by hydrophobic interactions involving Trp476 of each 
subunit, inter-monomer salt-bridges between Glu461 and Arg471, and inter-monomer 
backbone hydrogen bonds between Tyr469 and Arg471. It also contains an N-terminal 
hydrophobic stretch in the left-handed prolyproline II helix conformation between 
Pro460 and Pro463, which is connected to the -hairpin (residues 468-479) and forms a 
hydrophobic cap of the hairpin on the N-terminal side. The hairpin ends in a 310 helix at 
the C terminus with hemophilic interactions of several hydrophobic residues (Y458, 
I459, V470, L479, L483) between the monomers along the symmetry axis (145).  
The foldon domain was proposed to be an evolutionarily optimized 
trimerization motif, since its only known function is to promote the folding of fibritin. At 
neutral pH, the foldon domain forms a stable trimer; however, when changing from 
neutral to acidic pH, the monomeric state appears in the NMR spectra of foldon, which 
is in slow exchange with the trimer state. The monomer state becomes increasingly 
populated between pH 4.3 and pH 1.6, and riches maximum population at pH values 
below pH 2 and concentrations of lower than ~200 M (146).  
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Because of foldon’s natural trimerization property, it has been engineered as a 
protein tag to promote the trimerization of other proteins that are fused to it (147, 148). 
And it is a model system for studying oligomer structure because of its small size, high 
stability and dynamic property between monomeric and trimeric states. 
2.5.1 Detection and assignment of inter-monomer NOEs from 4-D 
omit NOE spectroscopy 
The omit NOE strategy described above can be conveniently applied to 
homooligomeric complexes, such as the homotrimeric foldon complex. In this case, two 
sets of sparsely sampled 4-D 13C HMQC-NOESY-HSQC spectra were collected for a 0.33 
mM uniformly 13C-labeled foldon sample and for a 1.32 mM sample containing 25% 13C-
labeled protein and 75% unlabeled (12C) protein, respectively. Since intermolecular 
NOEs are statistically diluted in the second sample, signal subtraction of the second 4-D 
NOE dataset from the first dataset generates an omit spectrum containing 
intermolecular NOEs. The scaling factor was chosen so that all diagonal NOEs are 
slightly negative in the omit spectrum (e.g., the negative diagonal signal of A462 QB in 
Figure 14A), ensuring that the remaining positive NOE crosspeaks in the omit spectrum 
arise from genuine intermolecular NOEs (e.g., black colored crosspeaks between R471’ 
and A462 in Figure 14A) and distinguishing these signals from the slightly negative 
intramolecular NOEs (e.g., intramolecular interactions between A462 and its neighbors; 
Figure 14). In total, 79 inter-monomer NOEs are identified from the 4-D omit spectrum. 
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Figure 14: Omit spectrum of the foldon trimer 
(A) F1-F2 slices of the corresponding 4-D spectra centered at 14.12 ppm in F3 and -0.49 
ppm in F4, displaying NOEs to the A462 methyl group. 4-D 13C HMQC-NOESY-HSQC 
spectra are collected for foldon with uniformly (left) or 25% (middle) 13C-labeled 
samples. Subtraction of these two spectra generates an omit spectrum (right) containing 
positive intermolecular NOE and negative (red) diagonal signals and intramolecular 
NOEs. (B) Interface of two subunits of the foldon trimer, showing an inter-subunit 
interaction between R471 and A462 and intra-subunit interactions between W476, Y469, 
P463 and A462. 
 
2.5.2 Automated structure calculation of foldon trimer 
Since the structure of the foldon trimer is already known, we examined whether 
intermolecular NOEs detected in the 4-D omit NOE spectrum can be used for automated 
structural analysis of homooligomers.  In order to achieve this, we first calculated the 
monomer structure of foldon using backbone resonances from 3-D sparse-sampled triple 
resonance experiments and sidechain resonances from 4-D sparse-sampled HC(co)NH-
TOCSY experiment. 4-D sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 13C-
HMQC-NOESY-HSQC experiments were collected using 25% 15N, 13C-labeled samples 
to generate distance constraints for the monomer. CYANA (149) was used for automated 
structure calculation of the monomer.  
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Secondly, intermolecular NOEs between monomers were generated as described 
above and assigned automatically by CYANA (149) using a modified protocol to ensure 
that they are assigned as intermonomer NOE and are grouped according to C3 
symmetry (see section 2.6.6 for detailed explanation).  
Finally, intermolecular NOE constraints were combined with monomer structure 
constraints applied to each subunit to calculate the final foldon trimer structure.  
Using intermolecular NOEs derived from the 4-D omit NOE spectrum, this 
strategy generates a highly-converged foldon structure with 0.6 Å  backbone RMSD 
deviation from the corresponding crystal structure (PDB 1OX3) (Figure 15), 
demonstrating the benefit of 4-D omit NOEs in this automated calculation for a 
homooligomer. 
 
Figure 15: Automated structure calculation of foldon 
The structural ensemble of trimeric foldon (subunits colored in blue, green and orange) 
calculated from the CYANA-assigned 4-D intermolecular NOE peak list from the omit 
spectrum superimposed with the crystal structure (grey; PDB ID: 1OX3). 
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2.5.3 Comparison of inter-monomer NOEs from 4-D omit NOE 
spectroscopy and 3-D half-filtered NOESY experiments for structure 
calculation 
In order to compare our new 4-D omit NOE spectroscopy strategy with 
traditional 3-D half-filtered NOESY, we collected a 3-D half-filtered 13C NOESY-HSQC 
experiment using the 25% 15N, 13C-labeled samples. NOE crosspeaks from this spectrum 
(Figure 16E) were picked and assigned following the same automated protocol as stated 
in Section 2.6.6 at different contour levels. However, due to assignment ambiguities, 
these crosspeaks cannot be analyzed by automated procedures in CYANA (149) to 
generate a properly converged fold, even when NOE crosspeaks are filtered at 30-fold 
and 90-fold above the spectral noise, respectively (Figure 16 C,D). This comparison 
demonstrated the advantage of our 4-D omit NOE spectroscopy in terms of homo-
oligomer structure calculation. 
 
Figure 16: Automated structure calculation of foldon using 3-D half-filtered NOE 
Panels C and D show the results of structure calculation using the 3-D half-filtered NOE 
peak list with intensity thresholds of 150K and 450K, respectively. E) A slice of the 3-D 
half-filtered NOE spectrum centered at the A462 methyl group, plotted at contour levels 
of 50K, 150K and 450K, respectively. 
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2.5.4 Pros and cons of applying 4-D omit spectra to homooligomer 
structure determination 
The successful demonstration of the 4-D omit NOE approach to the automated 
structural analysis of the foldon trimer is encouraging, but not without caveats. For 
example, it is not possible to obtain pure intramolecular NOEs using a homooligomeric 
sample containing both isotopically-labeled and unlabeled components. Instead, one 
obtains a spectrum containing intramolecular NOEs and significantly weakened 
intermolecular NOEs due to statistical dilution of intermolecular dipolar interactions. 
After slight over-subtraction of subunit-labeled data from uniform-labeled data to make 
sure all the intramolecular NOEs are either invisible or negative, the intensity of the 
intermolecular NOEs in the 4-D omit spectrum will be reduced as well. Therefore, the 4-
D omit spectrum in this case is less sensitive than the corresponding 3-D half-filtered 
NOE experiment in detecting intermolecular NOEs. However, as demonstrated with the 
foldon trimer, despite the superior sensitivity of the 3-D half-filtered NOE experiment 
(compare the omit spectrum in Figure 14 and the half-filtered spectrum plotted at 
different contour levels in Figure 16E), due to assignment ambiguities, these crosspeaks 
cannot be analyzed by automated procedures in CYANA (150) to generate a properly 
converged fold, even when NOE crosspeaks are filtered at 30-fold and 90-fold above the 
spectral noise, respectively (Figure 16CD). In contrast, the inclusion of an additional 
dimension in the 4-D omit spectrum largely eliminated the assignment ambiguity for the 
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automated NOE analysis protocol. Since the identity of the subunits contributing to 
intermolecular NOEs for a homooligomeric complex with C3 symmetry cannot be 
differentiated (e.g., interaction of A-B vs. A-C), these intermolecular NOEs are 
symmetrized in the order of A-B, B-C, and C-A, with the counter rotating pairs of A-C, 
B-A, C-B implemented as ambiguous constraints. When these constraints are used in the 
CYANA (150) calculation, they readily generate a highly-converged foldon structure with 
0.6 Å  backbone RMSD deviation from the corresponding crystal structure (PDB 1OX3), 
clearly demonstrating the advantage of 4-D omit NOE spectrum. 
Although not demonstrated here, variation of the high-resolution 4-D NOE 
experiment developed for the omit NOE approach can also be used for direct detection 
of intermolecular NOEs between 15N labeled monomer and 13C labeled monomers, 
further improving the robustness of structural analysis of homooligomeric protein 
complexes by NMR.  
The inability to detect pure intramolecular NOEs is a problem unique to 
homooligomeric protein complexes, which does not occur in heterodimeric or 
heterooligomeric protein complexes. This makes the omit NOE approach a much more 
attractive solution for studies of protein complexes consisting of distinct components. In 
the following two chapters, we apply the 4-D omit NOE experiments to studies of 
heterodimeric ubiquitin complexes with the Pol  UBM1and the FAAP20 UBZ in DNA 
repair pathways. 
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2.6 Materials and methods 
2.6.1 Molecular cloning 
The DNA sequence of the T4-fibritin foldon domain (residue 457-483) was 
synthesized; the PCR-amplified DNA was double digested and ligated into a modified 
pTRC-HisB vector (Invitrogen) between the BamHI and EcoRI restriction sites. The final 
construct contains an N-terminal His6 tag and thioredoxin tag followed by a thrombin-
cleavage site. The insertion of the DNA fragment was confirmed by DNA sequencing. 
2.6.2 Protein purification 
The N-terminal His6 and thioredoxin tagged foldon construct were 
overexpressed in Escherichia coli BL21 (DE3*) cells (Invitrogen). Bacterial cells were 
cultured in M9 minimal media using 15N-NH4Cl and 13C-glucose as the sole nitrogen 
and carbon sources (Cambridge Isotope Laboratories), and induced by IPTG (1 mM 
IPTG at 37°C for 3 hr). The overexpressed proteins were purified by a Ni2+-NTA column; 
then the N-terminal His6-thioredoxin tag of foldon were removed by thrombin cleavage, 
followed by passing through another Ni2+-NTA column and benzamidine column to 
remove the His6-thioredoxin tag and thrombin. Foldon protein was further purified by 
gel filtration column (Superdex 75, GE Healthcare).  
2.6.3 NMR sample preparation and data collection 
The uniform labeled NMR sample of foldon was prepared by buffer exchanging 
the protein after gel-filtration column into NMR buffer containing 10mM sodium 
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phosphate, 10%D2O or 100%D2O (pH=7.0) and concentrated to a final trimer 
concentration of 0.33mM. 
The 25% labeled NMR sample of foldon was prepared by mixing 13C, 15N-labeled 
foldon with unlabeled foldon at a molar ration of 1:3 and incubating for 6 hr (pH=2.0). 
The foldon samples were then exchanged into the NMR buffer and concentrated to a 
final concentration of 0.33 mM for uniformly labeled foldon and 1.3 mM for the 25% 
labeled foldon, respectively. 
NMR experiments were conducted at 25 °C using Agilent (Varian) INOVA 600 
MHz or Agilent (Varian) INOVA 800 MHz spectrometers. NMR data were processed by 
NMRPIPE (151) and SCRUB (141). NMR spectra were analyzed with SPARKY (152) and 
XEASY (153). Backbone resonances were assigned by four pairs of sparse-sampled 3-D 
triple-resonance experiments, and the side-chain resonances were assigned using the 4-
D sparsely-sampled HC(co)NH-TOCSY experiment. 
2.6.4 Generation of 4-D omit spectra and identification of inter-
monomer NOEs 
4-D sparsely-sampled 13C-HMQC-NOESY-15N-HSQC experiment was recorded 
for 25% 15N, 13C-labeled sample, and identical 4-D sparsely-sampled 13C-HMQC-NOESY-
HSQC experiments were recorded for uniformly and 25% 15N, 13C-labeled samples. The 
4-D sparsely-sampled 13C-HMQC-NOESY-15N-HSQC experiments used a mixing time of 
150 ms, with spectral widths of 62ppm for the 13C (t1 and t3) dimensions and 10.75 ppm 
for the 1H (t2) dimension and tmax of 5.16ms for the C(t1 and t3) dimension and 11.16ms 
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for the h(t2) dimension. Each experiment was recorded for 86 hr. The omit spectrum was 
generated by subtracting scaled FIDs of 25%-labeled complexes from those of the 
uniformly-labeled complex and reconstructed by SCRUB (141). The scaling factor 1.7 was 
chosen so that all the diagonal NOEs are slightly negative in the omit spectrum. 4-D 
intermolecular NOEs were identified from the positive peaks in the omit spectrum.  
2.6.5 3-D half-filtered NOESY and identification of inter-monomer 
NOEs 
For comparison, 3-D half-filtered 13C NOESY-HSQC experiment was recorded for 
the 25% 15N, 13C-labeled samples with a mixing time of 150 ms. The spectral widths were 
12.75 ppm for the indirect 1H (t1) dimension and 62 ppm for the 13C (t2) dimension. It 
used a tmax of 7.85ms for the 1H (t1) dimension and 4.84 ms for the 13C (t2) dimension 
with a total acquisition time of 120 hr and a minimum required phase cycle of 16 scans. 
3-D intermolecular NOEs were identified from this experiment at an intensity threshold 
level of 50k (a contour level of ~10-fold above the estimated spectral noise). 
2.6.6 Automated structure calculation for homooligomer 
Distance constraints for calculating the monomer structure were identified from 
4-D sparsely-sampled NOESY experiments using a 25% 15N, 13C-labeled complex sample 
to ensure the detected NOEs are dominated by intramolecular signals, as in such a 
sample, the intermolecular NOEs are statistically diluted and significantly weakened. 
Using the 4-D NOE peaks derived from the 25% labeled sample and dihedral angle 
constraints derived from TALOS+ (108) analysis of chemical shift information; we were 
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able to calculate the monomer structure of the foldon trimer using the automated 
protocol of CYANA (149).  
The default CYANA protocol for homodimeric structure calculation fails to work 
for protein complexes with C3 symmetry, as the default symmetrization method is 
incompatible with Cn symmetry. In order to overcome this issue and enable (semi-
)automated structural analysis of the foldon trimer, we took the following approach. In 
the first step, the intermolecular NOE peaks extracted either from the 4-D omit spectrum 
or from the 3-D half-filtered 13C NOESY-HSQC were used as input for the automated 
NOE analysis protocol (noeassign.cya) assuming a single chain foldon trimer. In this 
case, CYANA readily generates unbiased assignments, including intramolecular and 
intermolecular assignments, based purely on chemical shift information in the first cycle 
of structure calculation (cycle1.noa). In this step, two modifications were made to the 
default protocol (noeassign.cya): 1) Similar to the case of sparse methyl and amide NOEs 
for the global fold calculation, the weight of network anchoring was decreased in order 
to allow for the assignment of “lone” intermolecular NOEs; 2) Since we were interested 
in all intermolecular NOE assignments, the process of “constraint combination” was not 
used and the “cycle1-uncombined.upl” file, which contains all distance constraints, was 
used for generating intermolecular distance constraints. In the second step, the CYANA 
assignments were filtered to eliminate intramolecular assignment as the input peaklists 
from the 4-D omit spectrum or the 3-D half-filtered spectrum should only contain 
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intermolecular NOEs. In the third step, the intermolecular assignments were grouped 
based on symmetry. For homooligomeric protein complexes, there exists inherent 
subunit ambiguity. In the case of foldon with the C3 symmetry and subunits A, B, and 
C, an intermolecular NOE could occur between subunits A-B or A-C, but not necessarily 
both. As a result, six potential NOE assignments could be generated for an isolated 
signal, including three symmetry-related assignments of A-B, B-C, and C-A, and three 
alternative assignments of A-C, B-A, and C-B. These six assignments are grouped 
together as two sets of three distance constraints, with the alternative assignment 
implemented as ambiguous NOEs (i.e., A-B/A-C, B-C/B-A, C-A/A-B). In the final step, 
intermolecular NOE constraints were combined with monomer structure constraints 
applied to each subunit to calculate the final foldon trimer structure. 
Using the intermolecular NOE peak list from the 4-D omit spectrum, such a 
protocol generated a highly converged foldon trimer that superimposed well with the 
reported crystal structure. However, when the intermolecular NOE peak list (generated 
by manual peak picking at a contour level of 50k) from the 3-D half-filtered experiment 
was used as input, the calculation failed to converge (data not shown). In order to 
eliminate the possibility that the 3-D half-filtered NOE spectrum could contain residual 
incompletely filtered intramolecular NOE signals, the 3-D peak list was filtered again at 
an intensity threshold of 150k (30-fold above spectral noise) and at 450k (90-fold above 
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the spectral noise). The filtered peak lists with different intensity thresholds were used 
as input to calculate the structure ensembles shown in Figure 16C and 16D. 
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3. Structural study of the human polymerase  ubiquitin-
binding domain 1 (UBM1) in complex with ubiquitin 
3.1 Background 
3.1.1 Ubiquitin recognition in translesion synthesis 
3.1.1.1 Tranlesion synthesis 
Translesion synthesis (TLS) is a type of DNA damage tolerance mechanism in 
which DNA damage can be bypassed by specialized DNA polymerases (translesion 
polymerases) during genomic replication. Due to the low replication fidelity of 
translesion polymerases, TLS is an error-prone process and it promotes cell survival at 
the cost of replication fidelity (154, 155). Most of the TLS polymerases belong to the 
recently classified Y-family of DNA polymerases (156, 157), with the exception of pol ζ 
(Rev3/Rev7), which is a B-family polymerase (158). 
There are five subfamilies within the Y family: Rev1, UmuC, DinB/pol κ, pol η, 
and pol ι (157). Over 300 members have been identified to date within this family (159). 
E. coli has two TLS polymerases, Pol IV (DinB/pol κ) and Pol V (UmuC); S. cerevisiae also 
has two (Pol η and Rev1), while human has four Y-family polymerases: Pol η, Pol ι, Pol 
κ, and Rev1 (Figure 17). These polymerases differ in their preferred lesion substrates and 
catalytic efficiencies towards various lesions. 
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Figure 17: Cartoon representation of the protein domains in human TLS polymerases. 
aa: amino acids. Adapted from Waters LS et al. (154) 
 
The N-termini of the Y-family polymerases consist of a conserved polymerase 
domain of 350-450 residues, which is distinct from common replicative polymerases 
(replicases) (160, 161). A hallmark of TLS polymerases is a more spacious active site 
compared to replicases (162). The smaller thumb and finger domains of TLS 
polymerases give rise to a solvent-exposed active site (159), which is not nearly as 
constrained as those in the replicases. Besides making fewer contacts with the base pair 
that needs to be formed (163), the Y-family polymerases lack the O helix of replicases 
that rotates upon binding of a dNTP to sterically inspect the base pair formation (154). 
Also, Y-family polymerases lack the intrinsic 3’-5’ exonuclease domain that proofreads 
the newly replicated strand in many high-fidelity replicases (164). In addition, certain 
TLS polymerases, such as Rev1 and Pol ι do not use canonical Watson-Crick base 
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pairing (160, 165). Due to these special features of TLS polymerases, they exhibit error 
rates in the range of one in every 10,000 bases (as compared to one in every 106-108 bases 
for replicases) (164, 166). Therefore, TLS polymerases must be under tight regulation in 
order to achieve a balance between genetic instability and mutation rates. 
 
Figure 18: “Polymerase switch” during translesion synthesis 
When DNA damage stalls DNA replication, PCNA (orange) is monoubiquitinated 
(yellow for ubiquitin moiety), which recruits TLS polymerase Rev1 (green) to replace 
replicase (purple). Rev1 further serves as loading dock to recruit “inserter” (blue) and 
“extender” (pink and yellow, Rev7 and Rev3) together to bypass the DNA damage (167).  
 
The current widely accepted model for TLS is called “polymerase switch” (168-
170) (Figure 18). In this model, when replication is stalled at the DNA damage site, the 
proliferating cell nuclear antigen (PCNA) (171-173) is monoubiquitinated, which recruits 
one or more TLS polymerases in a translesionsome complex (167). Many of the TLS 
polymerases have a basal affinity for unmodified PCNA in vitro through their PIP 
domain (174-178) or the BRCT domain, in the case of Rev1 (179) (Figure 17). Thus, it is 
remains to be determined if the monoubiquitination of PCNA serves primarily to signal 
the need for TLS, serves to strengthen the interaction between PCNA and TLS 
polymerases via their ubiquitin-binding domains (Figure 17), and/or facilitates the 
switch between the replicases and the TLS polymerases in a translesionsome complex 
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(169). Once the inserter polymerase incorporates one or more nucleotides at the DNA 
damage site, the extender polymerase elongates the DNA chain to bypass the damage 
site. Afterwards, the replicase is switched back in to replace TLS polymerases for normal 
replication. Insertion determines the accuracy and mutagenic specificity of the TLS 
reaction, and is carried out by one of Y-family TLS polymerases such as Pol η, Pol κ, Pol 
ι or Rev1. In contrast, extension is carried out primarily by Pol ζ (180). 
 
Figure 19: PCNA ubiquitination and TLS  
When DNA damage occurs, PCNA is monoubiquitinated at K164 by Rad6 and Rad18, 
which promotes the recruitment of TLS polymerases to the DNA damage site for TLS. 
Monoubiquitinated PCNA can be further polyubiquitinated by Ubc13-Mms2/Rad5 with 
a K63-linked polyubiquitin chain which triggers error-free lesion bypass, including fork 
regression and template switching. Ubiquitination of PCNA is a reversible process, in 
which ubiquitin on PCNA can be removed by USP1 in human cells. Adapted from Yang 
et al (181) 
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3.1.1.2 Ubiquitination in TLS 
PCNA monoubiquitination is the key step of TLS activation. Following DNA 
damage that stalls the progression of the DNA replication fork, the highly conserved 
K164 of PCNA is monoubiquitinated by the E2 Rad6 and the E3 Rad18 (171, 182) (Figure 
19). PCNA monoubiquitination has been reported in a wide variety of organisms 
including yeast, Xenopus, chicken, and mammals. The uncoupling of the stalled 
replicative polymerase and the MCM helicase results in production of single-stranded 
DNA exposed in the vicinity of the stalled fork. This single-stranded DNA is coated by 
Replication Protein A (RPA), which in turn interacts with Rad18 and directs the 
Rad6/Rad18 complex to the site of DNA damage, triggering PCNA monoubiquitination 
(183, 184). 
Besides monoubiquitination, PCNA can also be further polyubiquitinated in the 
K63-linkage type at K164 by the E2/E2 variant Ubc13/Mms2 and the E3 Rad5 in many 
organisms including yeast (185). Rad18 recruits Rad5, which further recruits 
Ubc13/Mms2 through the RING finger domain of Rad5 (186-188). The addition of this 
chain activates the error-free template switching mechanism of DNA damage bypass 
(Figure 19) by dislodging TLS polymerases from PCNA, preventing the interaction of 
the TLS polymerases with PCNA, or recruiting factors that carry out template switching 
processes (189, 190). The mechanism of template switching is still poorly understood 
and is hypothesized to proceed by a ‘‘chicken foot’’ mechanism (191) or a homologous 
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recombination-like mechanism whereby the sister duplex is invaded by a single 
stranded gap, forming a D-loop (171, 189). In mammalian systems, PCNA 
polyubiquitination occurs at much lower levels (192). RAD18 and UBC13 are required 
for PCNA polyubiquitination in human cells, but MMS2 appears to be dispensable (193).  
Deubiquitination of PCNA acts as a safeguard against error-prone TLS. USP1 is 
the deubiquitinase (DUB) that removes the monoubiquitin from PCNA (194). Upon 
DNA damage, the level of USP1 decreases by an autocleavage event followed by 
proteasomal degradation of the cleaved products. 
TLS polymerases can also be ubiquitinated. Mammalian Pol η, Pol ι, Pol κ, and 
Rev1 have all been found to be ubiquitinated in vivo, modifications that depend on the 
presence of their intact UBDs and are Rad6-and Rad18-independent (51, 181, 195). The 
ubiquitination of these polymerases does not require an E3 enzyme, suggesting that the 
UBDs within the polymerases function as their own auto-ubiquitinating E3 ligases (195, 
196). This is not unusual, as the ubiquitination of UBD-containing proteins, in a UBD-
dependent manner, has been previously observed (10). Pol η is monoubiquitinated at 
four lysine residues close to its C-terminus (K682, K686, K694, and K709) (197), while the 
ubiquitinated residues in Pol ι remain to be determined. Monoubiquitination of Pol η 
precludes its interaction with PCNA, and upon DNA damage, Pol η is deubiquitinated. 
These observations support a regulatory role of Pol η monoubiquitination in DNA 
damage response. Rev1 can also be monoubiquitinated. A recent study showed that 
 59 
monoubiquitinated Rev1 can interact with FAAP20 of the Fanconi anemia core complex, 
which recruits the TLS machinery to DNA interstrand crosslink (ICL) sites (198).  
3.1.1.3 Ubiquitin-binding domains (UBDs) in TLS 
Monoubiquitinated PCNA is recognized by TLS polymerases such as Pol , Pol , 
Pol , and Rev1 via their ubiquitin-binding domains (UBDs), such as the ubiquitin-
binding motif (UBM) and ubiquitin-binding zinc finger (UBZ) in conjunction with motifs 
such as the PCNA-interacting protein (PIP) boxes that recognizes PCNA. Both the UBM 
and UBZ classes have been discovered through bioinformatics analysis of several yeast 
two-hybrid screens aimed at finding unconventional ubiquitin interactors (51). In TLS 
polymerases, the UBDs play an essential role in mediating the interaction between TLS 
polymerases and the monoubiquitinated PCNA and enhance their binding affinity. (172, 
195, 199-204).  
Pol ι and Rev1 contain two conserved UBM domains located in their C-terminal 
regions (14, 195). In Pol ι, both UBM domains are functional in binding ubiquitin and are 
important for localization of Pol ι to sites of DNA damage and replication foci (51). In 
mouse REV1, both UBM1 and UBM2 are found to be required for ubiquitin binding, and 
deletion of either domain greatly decreases the formation of nuclear foci of REV1 in cells 
(195). Interestingly, the yeast REV1 requires only UBM2 for ubiquitin binding and for its 
cellular function (64, 195, 205, 206). 
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Pol η contains one UBZ domain, while Pol κ contains two tandem UBZ domains 
in the C-terminal region. Mutations in the Pol η UBZ domain that disrupt the UBZ 
interaction with ubiquitin in vitro also greatly reduced the nuclear foci formation of Pol η 
in response to DNA damage in vivo (51, 200). Similar observations were made for Pol κ, 
again suggesting the important role of PCNA monoubiquitination in recruiting the TLS 
polymerases to DNA damage sites. The UBZ domain in the human Pol η was shown to 
be a classical C2H2 zinc-finger domain with a zinc ion sandwiched between an α-helix 
and two antiparallel β-strands through coordination with the conserved cysteine and 
histidine residues. The binding interface was mapped onto the -helix of UBZ and the 
I44 hydrophobic patch on ubiquitin based on the NMR chemical shift perturbation study 
(68). Intriguingly, the UBZ domain in S. cerevisiae Pol η shows a divergence from the 
conserved CXXC motif with the two cysteine residues juxtaposed next to each other in 
the primary sequence. Studies have shown that the yeast Pol η UBZ can bind ubiquitin 
in a zinc-independent manner (207, 208). The structure of the tandom UBZ domain of 
Pol  and its ubiquitin binding specificity remains to be elucidated. 
3.1.2 The UBM1 domain of Human Pol 
Human Pol  has very low processivity (209). It is able to insert bases opposite 
the lesion site, but is not able to extend synthesis beyond the inserted base. Human Pol ι 
is also a low-fidelity enzyme that incorporates dGMP opposite T 3 to 10 times more 
frequently than the correct nucleotide (210, 211). It also has a 5’- deoxyribose lysase 
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activity, suggesting a role in base excision repair (BER) in protecting cells from oxidative 
damage (212). In both BER and TLS, the recruitment of Pol ι requires both its nuclear 
localization site (NLS) and UBMs (200, 212). It is, like Pol , localized in replication 
factories and physically interacts with Pol  (200). Its recruitment to the DNA damage 
site depends on Pol η (213). Interestingly, Pol ι is even more mobile than Pol η with a 
shorter t1/2 (203). No human condition has been found to be associated with Pol  
deficiency. However, the 129 strain of mice, widely used in the generation of knockout 
mice, has an ochre mutation close to the N-terminus of the protein and appears to make 
nonfunctional protein (214). To date these mice have no reported unusual phenotype. 
 
Figure 20: Sequence alignment of UBM domains 
Conserved residues are highlighted, with the signature Leu-Pro motif in purple, 
hydrophobic residues in brown, and negatively charged residues in red. Adapted from 
Bomar et. al. (64) 
 
The UBM domains were originally identified by their unique ability to interact 
with an I44A ubiquitin mutant in a yeast two-hybrid screen and were predicted to be 
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composed of two helical segments with an invariant “Leu-Pro” motif in between (51) 
(Figure 20). Pol  contains two copies of UBM within the C-terminal region. Both of the 
UBMs in Pol ι bind to ubiquitin and are necessary for the accumulation of Pol ι to 
damage-induced replication foci (51, 200). Mutations within the UBMs of the 
polymerases do not alter the catalytic activity of the polymerase or its interaction with 
unmodified PCNA or other polymerases, but they impair their ability to function in vivo, 
possibly due to an affected affinity for binding to monoubiquitinated PCNA or other 
ubiquitinated target (51, 200, 206).  
The structure of human Pol  UBM2 in complex with ubiquitin has been 
determined, but the molecular details of the related UBM1 domain remain to be 
elucidated. To further understand the molecular mechanism of Pol  UBM-ubiquitin 
interaction and compare it with UBM2-ubiquitin structure, we applied 4-D fast NMR 
technique to determine the complex structure of the human Pol  UBM1-ubiquitin 
complex.  
3.2 Results 
3.2.1 Characterization of Pol  UBM1 and its complex with ubiquitin 
3.2.1.1 Interaction identification and binding affinity measurement of hUBM1-
ubiquitin complex 
The chemical shifts of protein residues are sensitive to subtle differences in the 
environment, including temperature, pH, and binding partners. Upon binding of the 
two proteins, the environment of the protein interface changes, affecting the chemical 
 63 
shifts of the nuclei involved in this association. Therefore, NMR titration can be used to 
map protein interfaces by titrating an unlabeled interaction partner into a labeled 
sample and recording the resulting chemical shift perturbations. The addition of 
unlabeled ubiquitin resulted in the chemical shift perturbation for a subset of resonances 
of the UBM1 domain, not the GB1 domain, indicating that the human Pol  UBM1 
domain is a functional ubiquitin-binding domain (Figure 21). The shifted peaks 
suggested that the UBM1-ubiquitin interaction is within the fast exchange regime, 
characteristic of most moderate-to-weak-affinity interactions. 
 
Figure 21: NMR titration of human Pol ι UBM1 domains with ubiquitin 
1H-15N HSQC spectra of human pol ι UBM1 with increasing amounts of ubiquitin. Initial 
(apo state) and final (complex state) points of titrations are depicted in red and purple.  
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Figure 22: NMR titration of ubiquitin with human Pol ι UBM1 domains 
1H-15N HSQC spectra of ubiquitin with increasing amounts of human pol ι UBM1. Initial 
(apo state) and final (complex state) points of titrations are depicted in grey and black. 
 
Furthermore, the binding affinities of a protein-protein interaction can be 
quantified based on the chemical shift perturbations. With the addition of unlabeled 
GB1-fused UBM1 into the 15N-labeled ubiquitin sample (Figure 22), the chemical shifts of 
a subset of residues of ubiquitin were perturbed. The first and last points of the titration 
are considered to be the unbound and bound states, respectively. In Figure 23A, the 
chemical shift corresponding to the free state of a representative amino acid I13 of the 
ubiquitin is shown in grey, and the saturated or bound state is depicted in black. These 
two points were connected by a series of titration steps; the normalized chemical shift 
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changes were calculated for each molar ratio and then used to determine the Kd value of 
the protein-protein interaction. When unlabeled GB1-fused UBM1 was added to an 15N-
labeled ubiquitin sample, resonances from residues V5, K6, T7, T9, K11, I13, I44, A46, 
L50, L67, V70 of the ubiquitin were significantly perturbed and the perturbations were 
used for binding-affinity calculation, resulting a Kd of 130±36 M (Figure 23B). The 
majority of these perturbed residues are located on the highly conserved, hydrophobic, 
concave surface of ubiquitin defined by residues L8, I44, and V70 (Figure 1).  
 
Figure 23: Chemical shift perturbation of ubiquitin titrated with human Pol  UBM1 
Determination of the binding affinity between the human Pol  UBM1 domain and 
ubiquitin by NMR titration. (A) A section of the 1H-15N HSQC spectrum depicting 
changes of the amide resonance for a representative residue, Ile13 of ubiquitin as the 
molar ratio of UBM1 to ubiquitin increased (grey to black). (B) Determination of the 
dissociation constant (Kd) by NMR. The chemical shift perturbations for the backbone 
amides of 11 residues (V5, K6, T7, T9, K11, I13, I44, A46, L50, L67 and V70) of ubiquitin 
were used to determine the binding affinity of the human Pol  UBM1 domain toward 
ubiquitin. 
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3.2.1.2 Backbone dynamics by heteronuclear NOE experiments 
In addition to structure determination, NMR can be used to study protein 
dynamics on a wide time scale, including characterizing the backbone dynamics of 
proteins in solution. For example, the local dynamics of a protein can be characterized 
by the 1H−15N heteronuclear NOE experiment (215), which is sensitive to motions on a 
picosecond to nanosecond time scale. A pair of experiments is recorded with or without 
the H spin being saturated. The intensities of the resonances in the two experiments can 
be compared to provide information about the motion of individual N-H bond vectors. 
The higher the saturated/unsaturated ratio is, the more rigid the backbone.  On the other 
hand, lower or negative values suggest increased local flexibility of the backbone. 
A 1H-15N heteronuclear NOE experiment was collected for free GB1-fused UBM1 
and GB1-fused UBM1-ubiquitin complex. Except for regions at their termini and the 
linker region between the GB1 tag and the UBM1 domain, both ubiquitin and UBM1 are 
quite rigid (Figures 24). 
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Figure 24: 1H-15N steady-state NOE data for human pol ι UBM1 and ubiquitin 
1H-15N Steady-State NOE data for GB1-UBM1 free (A) and bound to ubiquitin (B) and 
for ubiquitin bound to UBM1 (C). Y-axes show the intensity ratio of the saturated to 
unsaturated experiment. X-axes indicate the residue number of GB1-UBM1 or ubiquitin, 
respectively. The linker region between GB1 and UBM1 is composed of residues 57 and 
58. 
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The steady-state NOE data, together with the NMR titration of the GB1-fused 
UBM1 protein with ubiquitin, indicated that the GB1 tag and UBM1 domain are separate 
entities and connected by a flexible linker. The GB1 tag is not bound to ubiquitin, nor 
does it interfere with the ubiquitin-UBM1 binding interface. The establishment of linker 
flexibility between the solubility tag and fusion protein and the lack of interference by 
the solubility tag are two critical prerequisites for further structural studies on fusion-
tagged proteins. 
3.2.1.3 Determination of the oligomeric state by analytical ultracentrifugation 
Analytical ultracentrifugation experiments were performed to determine the 
oligomeric state of the UBM1 domain at various protein concentrations. Figure 25 shows 
a nonlinear least squares fit of the curve generated by sedimentation equilibrium. The 
molecular mass of UBM1 was in the range of 11.5 +/- 0.5 kDa at concentrations of 20, 40 
and 80 M as compared with an anticipated monomer molecular mass of 12.0 kDa. This 
suggests that the UBM1 domain is mainly monomeric in solution under these conditions, 
which are identical to those used in structure determination and binding studies. 
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Figure 25: UBM1 is a monomer in solution 
A pattern of the analytical ultracentrifugation data is shown for a 80 μM protein solution 
run at 20,000 rpm and at 20 °C. The best fit molecular weight was 11,313 Da (expected 
11,977 Da). 
 
 70 
 
Figure 26: Amino acid specific labeling of GB1-UBM1  
1H-15N HSQC spectra for each amino acid specific labelled GB1-UBM1 sample with 
peaks assigned, including Ile (A), Val (B), Leu (C), Phe (D) and Lys(E).  
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3.2.2 Solution structure of human PolUBM1 domain 
NMR was used to elucidate the solution structure of the human Pol UBM1 
complex(Figure 27). 4-D sparsely-sampled HNCACB and HN(co)CACB experiments 
were used for the backbone assignment. However, due to the severe overlapping of the 
signals in the center area of the 1H-15N-HSQC spectrum, the sequential assignment could 
not be completed. Therefore, we used the amino acid type specific labeling method to 
obtain the 1H-15N-HSQC spectrum for certain types of amino acid residues, including 
Lys, Val, Ile, Leu, and Phe (Figure 26) (216). These individual subsets of 1H-15N 
resonances provided clues for the backbone assignment while also serving as cross 
checks to confirm the existing assignments from the 4-D data. 3-D triple resonance 
experiments were also collected to confirm the backbone assignments and obtain the CO 
resonance information (217). 4-D sparsely-sampled HC(co)NH and HCCH TOCSY 
experiments were used for the side chain assignments. 4-D sparsely-sampled 15N- and 
13C-separated NOESY-HSQC experiments were used to generate distance constraints. 
Residual dipolar couplings (1DHN, 1DHaCa) were measured to generate orientation 
constraints. 
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Figure 27: Solution structure of human pol ι UBM1 
Structure of human pol ι UBM1. (A) Backbone traces of the NMR ensemble of 10 
structures. Helices and loops are colored in red and grey respectively. (B) Cartoon 
representation.  
 
Except for residues at the termini, human Pol UBM1 is well structured (Figure 
27), with a mean pair-wise RMSD of 0.35 Å  and 1.06 Å  for the backbone and heavy 
atoms of residues 498-520, respectively. The structure of UBM1 consists of two 
amphipathic helices that are supported by an N-terminal loop folding back to form a-
turn structure. The N-terminal loop adopts a typical -strand conformation, with the 
side chains of two residues (L498 and P499) interacting with the hydrophobic surfaces of 
the first helix following it. Helix 1 contains a single turn (Q504 to F507) and is positioned 
at a sharp angle with respect to the N-terminal loop. The stability of this short helix is 
greatly enhanced by the presence of the prototypical N-terminal helix cap residues (218) 
D503, with its sidechain forming hydrogen bonds with the amides of Q504 and V506. 
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The C-terminal helix (2) is longer than helix 1, extending from residue V512 to S520. 
The two helices lie within a plane at an angle of ~50-60 degree, and they are connected 
by a short loop containing the signature “Leu-Pro” motif poised for interaction with 
ubiquitin. The two helices are packed together by the interactions of the core aromatic 
residue F507 of 1 and other hydrophobic residues, including V502 and L510 flanking 
helix 1, and I514, I518, L519 of helix 2. Notably, an analysis of the UBM1 structure with 
the DALI server did not identify any known structure other than ones in the UBM 
family with a similar fold. 
3.2.3 Detection and assignment of intermolecular NOEs from 4-D omit 
NOE spectroscopy 
The intermolecular NOEs of the human Pol ι UBM1-ubiquitin complex were 
determined using the sparsely-sampled 4-D 13C HMQC-NOESY-HSQC omit NOE 
experiment. Three samples of gb1UBM1-ubiquitin complexes were prepared, including 
(1) a uniformly 13C/15N-labeled complex, (2) a ubiquitin selectively labeled complex, and 
(3) a gb1UBM1 selectively labeled complex, all at 3 mM concentration. Such a high 
sample concentration is necessary due to the weak binding affinity between UBM1 and 
ubiquitin to ensure the vast majority of the protein remains in the complex form. Three 
identical 4-D 13C HMQC-NOESY-HSQC experiments, each taking 43 hrs, were recorded 
for each sample, using cosine-weighted random concentric shell sampling (134) with 
3190 sampling points digitized on a 64x96x64 grid for the c(t1)-h(t2)-C(t3) indirect 
dimensions, corresponding to 0.8% of sampling points required for Nyquist sampling. 
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The omit spectrum was generated by subtracting scaled FIDs of component-labeled 
complexes from those of the uniformly-labeled complex and reconstructed by SCRUB 
(141). To account for the minor difference of NOE crosspeak intensities in the three 
samples, it is preferable to slightly over-subtract the component-specific NOE signals so 
that all of the diagonal signals are negative. This ensures that the remaining positive 
signals represent genuine intermolecular NOEs, whereas intramolecular crosspeaks are 
either completely removed or appear as weak negative signals (Figure 28). 
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Figure 28: Omit spectrum of the human Pol ι UBM1-ubiquitin complex showing 
intermolecular NOEs.  
4-D 13C HMQC-NOESY-HSQC spectra are collected for the gb1UBM1-ubiquitin complex 
with both components or with individual components 13C-labeled. Reconstruction of the 
difference time domain signals of the uniformly labeled protein complex sample from 
component-labeled samples generates an omit spectrum containing only intermolecular 
NOEs. Slight over-subtraction of time domain data from individual components 
generates negative diagonal signals (red) in the omit spectrum and ensures all of the 
positive cross-peaks originate from intermolecular NOEs. (A) aliphatic regions and (B) 
aromatic regions show sections of F1-F2 slices of the corresponding 4-D spectra centered 
at 24.53 ppm in F3 and 1.05 ppm in F4, displaying NOEs to the ubiquitin L8 methyl 
groups. Boxed peaks or peaks labeled with asterisks are off-plane signals. 
 
A large number of intermolecular NOEs can be observed in the 4-D omit 
spectrum, providing ample constraints to define the UBM1-ubiquitin binding interface. 
In particular, numerous intermolecular NOEs between UBM1 residues (V502 from the 
N-terminal tail, V506 and F507 from the α1, L510 from the turn between the two helices, 
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I514 and I518 from α2 and F527 from the C-terminal tail) and the L8 methyl groups of 
ubiquitin are detected in the 4-D omit spectrum (Figure 28). 
Of note, the employment of 4-D omit NOE strategy is particularly important in 
obtaining the complete set of intermolecular NOEs, as many intermolecular NOEs 
involving L8 methyl groups would be lost in 3-D filtered NOE experiments due the 
degenerate 1H chemical shifts of the interacting functional groups. The excellent signal 
separation of the aromatic rings of F507 and F527 is also critical to establish the UBM1 C-
terminal tail interaction with ubiquitin (Figure 28B), a distinct feature that separates the 
UBM1-ubiquitin interaction from the UBM2-ubiquitin interaction. 
3.2.4 Solution structure of human PolUBM1-ubiquitin complex 
The solution structure of the Pol UBM1-ubiquitin complex was determined 
with 4184 NOEs (including 293 intermolecular NOEs), 190 dihedral angles, and 86 
hydrogen-bond constraints. Except for residues at both termini, the UBM1-ubiquitin 
complex is well structured, with mean RMSD values of 0.34 Å  and 0.87 Å  for the 
backbone and heavy atoms, respectively, of residues 496-527 of Pol and 1-74 of 
ubiquitin. A final structural ensemble of 10 structures (Figure 29) was generated with no 
NOE violations > 0.5 Å  and no dihedral angle violations > 5°. The quality and statistics of 
these structures can be evaluated in Table 2. 
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Figure 29: Structure of the human Pol ι UBM1-ubiquitin complex. 
(A) Backbone trace of the NMR ensemble of 20 structures. Human Pol ι UBM1 is colored 
in blue, ubiquitin is colored in red. Two helices of human Pol ι UBM1 are labeled with 
α1 and α2.  (B) Ribbon diagram of the complex, with human Pol ι UBM1 in blue and 
ubiquitin in red. 
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Table 2: Structural statistics for human Pol  UBM1-ubiquitin complex 
Structural statistics for the human Pol  UBM1-ubiquitin complex (20 structures)a 
Pol  UBM1 (62-99)   
NOE distance restraints  898 
Intra-residue   210 
Sequential  263 
Medium-range (1< |i-j| 4)  317 
Long-range (|i-j|  5)  108 
Hydrogen bond constraintsb  18 
Dihedral angle constraintsc  66 
Ubiquitin (1-76)   
NOE distance restraints  2993 
Intra-residue  414 
Sequential  628 
Medium-range (1< |i-j| 4)  634 
Long-range (|i-j|  5)  1317 
Hydrogen bond constraintsb  68 
Dihedral angle constraintsc  124 
Intermolecular NOE distance constraints  243 
   
Target function value  0.86  0.12 
   
Ramachandran plotd   
Favored region (98%)  94.3 
Allowed region (>99.8%)  100.0 
   
Mean pairwise RMSD   
(Pol  UBM1 64-96; Ubiquitin 1-74)   
Backbone   0.34  0.06 Å  
Heavy Atoms   0.87  0.12 Å  
a None of these structures exhibit distance violations greater than 0.5 Å  or dihedral angle 
violations greater than 5. 
b Two constraints (dHN-O ≤ 2.5 Å and dN-O ≤ 3.5 Å) are used for each identified hydrogen bond. 
c Dihedral angle constraints were generated by talos+ based on backbone atom chemical shifts, 
and by analysis of NOE patterns (108). 
d MolProbity was used to assess the quality of the structures (219). 
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The ubiquitin moiety adopts an roll topology with a long -helix and a 
smaller 310-helix packing against the main -sheet containing five strands. The canonical 
hydrophobic surface, located centrally on the solvent-exposed surface of the -sheet and 
known for interacting with most ubiquitin-binding domains, is recognized by residues 
from the two helices of UBM1; however, the overall binding area is noticeably shifted 
toward L8 instead of centering at I44 (Figure 30), a critical residue for most ubiquitin-
binding domain (UBD)-ubiquitin interactions (220).  
 
Figure 30: Ubiquitin-binding interface with human Pol ι UBM1 
Side view (A) and front view (B) of the ubiquitin-binding interface on UBM1 depicting 
an interaction network centered at L8, instead of I44, of ubiquitin. UBM1 is depicted in 
blue and ubiquitin is shown in red. Side chains of UBM1-interacting residues are shown 
in the stick model on ubiquitin. 
 
A set of hydrophobic residues of UBM1, including V502 located to the N-
terminal of helix 1, V506, F507 of helix 1, L510 of the invariant “Leu-Pro” motif 
connecting helices 1 and 2, I514 and I518 of 2 and F527 of the C-terminal loop form a 
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network of hydrophobic interactions encircling L8 of ubiquitin (Figure 31). This is 
supported by numerous 4-D intermolecular NOEs detected between UBM1 and L8 of 
ubiquitin (Figure 28). This core binding interface is further supported by peripheral 
hydrophobic interactions formed between V506, L510, P511 and I514 of UBM1 and I44 
and the aliphatic side chains of K6 and H68 of ubiquitin. Similar to other UBM domains, 
the invariant “Leu510-Pro511” motif of UBM1 plays an important role in supporting 
ubiquitin binding, with the side chains of L510 inserting into the hydrophobic pocket of 
ubiquitin defined by L8, I44, H68 and V70, and P511 nudging into the shallow surface 
groove formed by I44, G47 and Q49.  
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Figure 31: Interface of the human Pol ι UBM1-ubiquitin complex, showing an 
interaction network centered at L8 of ubiquitin. 
UBM1 is depicted in pale blue and ubiquitin is shown in pale pink. Side chains of L8 of 
ubiquitin is shown in the stick model and colored in red. L8-interacting residues of 
UBM1 are shown in the stick model and colored in blue. 
 
The interaction between ubiquitin and UBM1 also appears to depend critically on 
the stability of the N-terminal short helix in UBM1. The N-terminus of α1, including the 
highly conserved N-cap residue of α1, D503, is located in the vicinity of the ubiquitin 
surface and is involved in the interaction with ubiquitin. Its amide group forms a 
hydrogen bond with the carbonyl group of L8 of ubiquitin, thus providing an anchoring 
point for ubiquitin binding. Such a configuration is well supported by intermolecular 
NOEs between D503 Hα and Hβ protons of human UBM1 and the Hα3 protons of G10 
of ubiquitin (Figure 32) 
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Figure 32: Omit spectrum of the human Pol ι UBM1-ubiquitin complex showing 
intermolecular NOEs of D503 
2-D slices of the 4-D 13C HMQC-NOESY-HSQC spectra centered at 45.07 ppm in F3 and 
3.51 ppm in F4, illustrating NOEs to the G10 H3 proton of ubiquitin. Boxed peaks are 
off-plane signals. 
 
3.3 Discussion 
3.3.1 Unique ubiquitin recognition by UBM 
UBM adopts a unique protein fold that has not been observed in other UBDs 
previously. In addition, the ubiquitin recognition mode of UBM is also distinct from all 
the other known UBDs. UBM belongs to the -helical UBD family, but its interaction 
with ubiquitin is centered at L8, instead of I44 of ubiquitin as seen for other -helical 
UBDs. UIM, MIU/IUIM and DUIM all use a single helix to bind to the solvent-exposed 
-sheet of ubiquitin (40-43, 58), with the ubiquitin-binding helix oriented either parallel 
or antiparallel to the central β-strand of ubiquitin (5) (Figure 33A). In contrast, UBM 
binds to ubiquitin using two consecutive helices, with helix 1 being perpendicular to 5 
of ubiquitin and helix 2 poised at an angle. The usage of two -helices has been seen in 
UBA-ubiquitin recognition (61, 62, 221). However, UBA uses two discontinuous helices, 
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1 and 3 of the three-helix bundle, which arranges in an “up-up” topology, whereas 
the two -helices of UBM are in an “up-down” topology (Figure 33B). The GAT domain 
also use 1 and 2 to interact with ubiquitin (47, 222), however, they are almost 
antiparallel with each other, whereas two -helices of UBM are at angles of about 50-60° 
on the same plane (Figure 33C). Therefore, UBM utilizes a distinct ubiquitin recognition 
mode.  
 
Figure 33: A unique mode of ubiquitin recognition by UBM1 
(A) Ubiquitin binding by UIM (green, PDB 1YX5) occurs via a single helix. Ubiquitin 
binding by UBA (magenta, PDB 2JY6) and GAT (orange, PDB 1YD8) as representative 
domains containing three-helix bundles is shown in panel B and C, respectively. UBM is 
colored in blue. Ubiquitin is in grey surface mode.  
 
3.3.2 Structure comparison of UBM homologs 
Compared with human Pol  UBM2-ubiquitin complex structure (64), human Pol 
 UBM1-ubiquitin complex adopts an overall similar fold and shares similar interface 
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with ubiquitin. The two structures overlay fairly well, with r.m.s.d. of 0.8 Å  (Figure 
34A). They both contain two -helices with almost identical angles. The “Leu-Pro” motif 
between the two helices plays an important role in interacting with ubiquitin. The major 
difference in the UBM portion is that the second helix in UBM1 is one helix turn shorter 
than in UBM2. This is due to the sequence difference between UBM1 and UBM2. The 
replacement of conserved Trp in UBM2 with Lys in UBM1 disrupts the second helix, 
which makes the hydrophobic core of UBM1 smaller than UBM2. The N-terminal loop 
in both structures adopts a similar turn. In UBM2-ubiquitin complex structure, the C-
terminal tail is disordered; however, the C-terminal loop of UBM1 folds back and 
extends towards ubiquitin for interacting with the C-terminal part of 5 and the loop 
containing L8 of ubiquitin (Figure 34A).  
Almost at the same time as we were finishing our work on the human Pol  
UBM1-ubiquitin complex structure, the mouse Pol  UBM1-ubiquitin complex structure 
was also determined by solution NMR (63). Mouse UBM1 also contains two -helices for 
interacting with the hydrophobic patch of L8 of ubiquitin. Interestingly, structural 
comparison of the human Pol ι UBM1-ubiquitin complex determined by 4-D NOE with 
the mouse Pol ι UBM1-ubiquitin complex (PDB 2KWV) has revealed larger-than-
expected structural deviation at the N-terminus of α1 of UBM1 (Figure 34B). In the 
human Pol ι UBM1-ubiquitin complex, the N-terminus of α1, including the highly 
conserved N-cap residue of α1, D503, is located in the vicinity of the ubiquitin surface 
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and is involved in the interaction with ubiquitin. Such a configuration is well supported 
by intermolecular NOEs between D503 Hα and Hβ protons of human UBM1 and the 
Hα3 protons of G10 of ubiquitin (Figure 32). In contrast, in the mouse Pol ι UBM1-
ubiquitin complex structure, the N-terminus of α1 is tilting substantially away from 
ubiquitin, in which the shortest distances between ubiquitin G10 Hα protons (i.e. Hα3) 
and the Hβ protons of the corresponding Asp in UBM1 (D501 in mouse Pol ι UBM1) are 
over 7.4 Å. The ubiquitin G10 Hα3 and mouse UBM1 D501 Hα protons are located 
further apart, with a distance of ~10.5 Å , reflecting a lack of intermolecular NOEs 
between these protons.  
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Figure 34: Structure comparison of UBM homologs 
(A) overlay of the human Pol  UBM1-ubiquitin complex (blue, this work) with UBM2-
ubiquitin complex (magenta, PDB ID 2KHW). The difference between the C-terminal 
parts of the two UBM domains is shown in the lower zoomed-in panel. (B) Overlay of 
the human Pol ι UBM1-ubiquitin complex (blue; this work) with the mouse Pol ι UBM1-
ubiquitin complex (yellow; PDB ID 2KWV) by superimposing the ubiquitin part. The 
zoom-in panel shows the distances between the ubiquitin G10 H3 proton and the H 
proton of a conserved UBM1 Asp residue (D503 in human Pol ι UBM1 and D501 in 
mouse Pol ι UBM1). 
 
3.3.3 Implication on the molecular mechanism of Pol  UBM-ubiquitin 
recognition in translesion synthesis 
The UBM domains appear to have important effects on Pol ι function. Studies 
have showed that foci accumulation of Pol ι in S phase of undamaged cells requires two 
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functional UBMs (64). Deletion of either of the two UBMs of Pol ι abolishes its 
accumulation at the replication foci. In undamaged cells, the amount of 
monoubiquitination of PCNA is very limited. Therefore, this data suggests that the 
UBMs of Pol ι are engaged in recognition of other proteins, most likely in their 
ubiquitinated form, at replication foci. In this regard, it is worth noting again that 
besides PCNA, all four mammalian Y-family polymerases can also be ubiquitinated (51, 
201, 223) . Therefore, the UBMs may serve as a scaffolding unit to recruit ubiquitinated 
replication factors, forming a UBM-mediated interaction network for the assembly of the 
translesionsome, while monoubiquitination of PCNA upon DNA damage can further 
enhance this assembly process.  
Our study shows Pol  UBM1 and UBM2 adopt a similar ubiquitin recognition 
mode, which is centered on L8 of ubiquitin instead of canonical I44 of ubiquitin. It will 
be interesting to elucidate whether this unique ubiquitin recognition mode of the UBM 
domains is required for normal Pol function. When the UBZ domain of Werner helicase 
interacting protein 1 (Wrnip1) was exchanged with the Pol ι UBM1 domain, foci 
formation of Wrnip1 was abolished (224). This data suggests that L8-centered ubiquitin 
interaction by UBM1 cannot be replaced with I44-centered ubiquitin interaction by 
WRNIP UBZ. Similar domain swapping experiments can be done to illustrate the 
specific function of Pol ι UBM domains. The Pol UBZ domain can be swapped in for 
either UBM1 or UBM2 or both UBM domains of Pol ι to test the importance of L8-
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centered ubiquitin recognition in Pol ι function. The two UBM domains of Pol ι can be 
swapped to test the relative importance of the two UBM domains in Pol ι. This might 
help explain whether the presence of two UBM domains in Pol ι is simply for enhanced 
interaction with ubiquitin or whether each UBM domain has a dedicated function.  
Another interesting question is whether the specificity of Pol ι UBM domain 
function depends on the context of ubiquitination. In other words, if the UBM domain 
can interact with ubiquitinated replication factor and if this interaction is required for 
Pol ι function, it will add another level of complexity to this highly controlled 
translesion synthesis process. 
3.4 Materials and Methods 
3.4.1 Molecular cloning 
The DNA sequence corresponding to the UBM1 domain of human DNA Y family 
polymerase residue 491-530) was synthesized. PCR-amplified DNA was digested and 
ligated into a modified pET30 vector (EMD Biosciences, Inc.) between the BamHI and 
XhoI restriction sites. The final construct contains an N-terminal GB1 tag (225) and C-
terminal His6 tag. For the construct used in the amino acid type specific labeling, the 
DNA fragment containing the GB1 tag, the UBM1 sequence and the His tag was 
digested from the pET30 vector and inserted into pET21a vector. (EMD Biosciences, Inc.) 
The DNA sequence of human ubiquitin was PCR-amplified from a human cDNA library 
and cloned into the pET15b vector (EMD Biosciences, Inc.), with an N-terminal His6 tag 
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and a thrombin cleavage site in between. The presence of the correct inserts of these 
constructs was confirmed by DNA sequencing. 
3.4.2 Protein purification 
The GB1-fused human Pol UBM1 protein of was overexpressed in Escherichia 
coli BL21(DE3) STAR cells (Invitrogen). For amino- acid type specific labeling, the GB1- 
fused UBM1 protein was overexpressed in Escherichia coli DL39 cells (LeMaster D.M.). 
Bacterial cells were induced at 20 ºC with 0.25 mM IPTG for 18 hours. Cells from a 1 L 
culture were collected by centrifugation and lysed by French press in 30 mL of lysis 
buffer (50 mM phosphate, 300 mM NaCl, 0.1% -mercaptoethanol, pH=8). Cell lysates 
were cleared by centrifugation and loaded onto a Ni2+-NTA column (Qiagen). The GB1-
fused UBM1 protein was eluted with at least five column volumes of elution buffer (50 
mM phosphate, 300 mM NaCl, 250 mM imidazole, 1% - mercaptoethanol, pH=8). The 
elution fractions containing protein were concentrated to 2ml with Amicon Ultra Filters 
(3000 Da cutoff, Millipore). The GB1-fused hUBM1 protein is further purified using size 
exclusion chromatography (Superdex 75, GE Healthcare) with a buffer containing 25mM 
phosphate, 100 mM KCl, 1% mercaptoethanol, pH=7. 
The human ubiquitinwas overexpressed in Escherichia coli BL21(DE3) STAR 
cells (Invitrogen). Bacterial cells were induced at 20 ºC with 1 mM IPTG for 18 hours. 
Cells from a 1 L culture were collected by centrifugation and lysed by French press in 25 
mL of lysis buffer (50 mM phosphate, 300 mM NaCl, pH=8). Cell lysates were cleared by 
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centrifugation and loaded onto a 5ml Ni2+-NTA column (Qiagen). The ubiquitin was 
eluted with at least five column volumes of elution buffer (50 mM phosphate, 300 mM 
NaCl, 250 mM imidazole, pH=8). The elution fractions containing protein were 
concentrated with Amicon Ultra Filters (3000 Da cutoff, Millipore) and buffer exchanged 
into gel-filtration buffer (25 mM phosphate, 100 mM KCl, pH=7) to remove the 
imidazole. Five units of thrombin (Haemotologic Technologies, Inc.) were added for 
digestion to remove the N-His6 tag. Thrombin was removed by loading the sample onto 
a 1-mL benzamidine column (GE Healthcare); the protein was collected in the flow 
through and washed with the gel filtration buffer (100 mM KCl, 20mM phosphate, 
pH=7). The flow through was added to the Ni2+-NTA column to remove the N-His6. The 
untagged ubiquitin was collected in the flow through by rinsing with the gel-filtration 
buffer. The flow through and washes was concentrated and further purified using size-
exclusion chromatography (Superdex 75, GE Healthcare) with the gel-filtration buffer. 
3.4.3 Analytical Ultracentrifugation 
The molecular weight of the free UBM1 domain in 25 mM phosphate, 100 mM 
KCl (pH=7.0) was estimated by sedimentation equilibrium at 20,000 rpm at 20 °C on a 
Beckman model XL-A Analytical Ultracentrifuge. The vbar of the protein and of the 
solvent at 20 °C were estimated to be 0.727 and 1.0043, respectively, by the SEDNTRP 
program. The protein was examined at several concentrations (20 M, 40M and 80 M) 
and monitored by the absorbance at 292 nm. Nonlinear least square curves were 
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generated by the IDEAL-1 program (Beckman). The analytical centrifugation experiment 
was performed by Harvey Sage (Duke University). 
3.4.4 NMR titration for measurement of binding affinity 
The Kd value for the human Pol  UBM1-ubiquitin complex was calculated based 
on NMR titration data. Unlabeled GB1 fused-UBM1 was titrated with increasing molar 
ratios into a 0.5 mM sample of the 15N-labeled ubiquitin. Normalized chemical shift 
changes () were calculated as 22 )2.()( NHN o   for each molar ratio (M).  
The dissociation constant (Kd) and value of maximum chemical shift perturbation 
(max) were extracted from perturbation data of 11 nonoverlapping residues, V5, K6, T7, 
T9, K11, I13, I44, A46, L50, L67, V70 using the equation: 
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3.4.5 NMR sample preparation and data collection for structure 
determination 
To prepare isotope-labeled sample, bacterial cells were cultured in M9 minimal 
media using 15N-NH4Cl and 13C-glucose as the sole nitrogen and carbon sources 
(Cambridge Isotope Laboratories). For amino acid type specific labeling, bacterial cells 
were cultured in M9 minimal media using 15N labeled amino acid with unlabeled NH4Cl 
and glucose. Purified protein was buffer exchanged into NMR buffer (100mM KCl, 
25mM phosphate, pH 7) with either 10%D2O or 100%D2O and concentrate to final 
 92 
concentration of 3mM for both apo GB1-fused UBM1 and GB1-fused UBM1-ubiquitin 
complex. 
NMR experiments were conducted at 25 °C using Agilent INOVA 600 or 800 
MHz spectrometers. 4-D sparely-sample HNCACB and HN(co)CACB experiments and 
four pairs of sparse-sampled 3-D triple-resonance experiments were collected for 
backbone resonances assignment. 4-D sparsely-sampled HC(co)NH-TOCSY and HCCH 
TOCSY experiments were collected for the side-chain resonances assignment. The 
traditional 3-D 15N-separated NOESY-HSQC experiments using a uniformly 15N-labeled 
complex sample and the 4-D sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 13C-
HMQC-NOESY-HSQC experiments using a uniformly 15N, 13C-labeled sample were 
collected for NOE assignments.  
NMR data were processed by NMRPIPE (151) and SCRUB (141). NMR spectra were 
analyzed with XEASY (153) and  SPARKY (152).  
3.4.6 Generation of 4-D omit spectra and identification of 
intermolecular NOEs  
For intermolecular NOE identification, three identical 4-D 13C HMQC-NOESY-
HSQC experiments were recorded for each sample (uniformly 15N, 13C-labeled, ubiquitin 
selectively labeled and gb1UBM1 selectively labeled). Each experiment used a mixing 
time of 150ms, with spectral widths of 70ppm for the 13C dimensions (t1 and t3) and 
11ppm for the 1H(t2) dimension and t max of 4.54ms for the 13C (t1 and t3) dimensions and 
10.85ms for the 1H (t2) dimension. Each experiment was recorded for 43 hr. The omit 
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spectrum was generated by subtracting scaled FIDs of gb1UBM1-labeled complexes and 
ubiquitin-labeled complex from those of the uniformly-labeled complex with the scaling 
factor of 1.07 and 1.05, respectively and reconstructed by SCRUB (141). Intermolecular 
NOE crosspeaks from the omit spectrum were analyzed manually.  
3.4.7 Heteronuclear NOE experiment 
The heteronuclear 1H-15N NOE experiments (215) were conducted using a 1mM 
15N-labeled GB1-fused UBM1 sample for the measurements of the apo state of UBM1 
and using a 2mM GB1-fused UBM1-ubiquitin complex sample for the measurements of 
UBM1 and ubiquitin in the complex state. The buffer condition was the same as in the 
NMR structural study. The 1H-15N NOE values were calculated from the ratios of peak 
intensities in the saturated versus unsaturated spectra.  
3.4.8 Residual Dipolar Coupling (RDC) measurement 
Residual dipolar couplings (1DHN, 1DHC) of free UBM1 were determined from the 
difference in couplings between an isotropic and a liquid crystalline Pf1 phage (101) 
sample (~20mg/ml) or a DMPC/DHPC bicelle sample (7% liquid with q=2.9, 13% 
cholesterol sulfate) (226). The buffer condition was the same as in the NMR structural 
study. A 3-D JHN-coupled HNCO TROSY and a 3-D JHC-coupled HNCO TROSY 
experiment (227) were used to measure the 1DHN and 1DHCcouplings, respectively. 
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3.4.9 Structure calculation 
For the UBM1 apo structure, NOE crosspeaks from 3-D 15N-separated NOESY-
HSQC and 4-D sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 13C-HMQC-
NOESY-HSQC were used for automatic CYANA (149) structure calculation and 
refinement in the presence of orientation constraints derived from the two sets of RDC 
measurement in two different alignment media and dihedral angle constraints derived 
from TALOS+ (108) analysis of chemical shift information. 
Manually-assigned intermolecular NOE crosspeaks were converted into distance 
constraints using the calibration module in CYANA (149). NOE crosspeaks from 3-D 15N-
separated NOESY-HSQC and 4-D sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 
13C-HMQC-NOESY-HSQC using a uniformly labeled complex sample were used for 
automatic CYANA (149)structure calculation and refinement in the presence of manually 
assigned intermolecular NOE constraints and dihedral angle constraints derived from 
TALOS+ (108) analysis of chemical shift information. The final structural ensembles (20 
structures) of the human Pol ι UBM1-ubiquitin complex display no NOE violations > 0.5 
Å  and no dihedral angle violations > 5 °. The statistics of the structural ensemble is 
shown in Table 2. The human Pol ι UBM1-ubiquitin complex structure has been 
deposited in RCSB and BMRB (PDB ID: 2mbb; BMRB ID: 19394). 
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4. Structural study of human FAAP20 ubiquitin-binding 
zinc finger domain (UBZ) in complex with ubiquitin 
4.1 Background 
4.1.1 Fanconi Anemia (FA) pathway 
Fanconi Anemia (FA) is a rare autosomal recessive or X-linked genetic disease, 
which was discovered by the Swiss pediatrician, Dr. Guido Fanconi, in 1927. Clinically, 
this chromosomal instability disorder is strikingly heterogeneous. Its hallmarks are bone 
marrow failure, congenital abnormalities, and early onset of cancer. Even though it is a 
rare disease (the disease affects at minimum 1 in 100,000 individuals (228)), Fanconi 
Anemia today has become a very well established model system for several biological 
processes, including DNA repair, cancer progression and protein ubiquitination (229-
234).  
The hallmarks of FA at the molecular level are the cellular hypersensitivity to a 
series of DNA damaging agents (235) such as diepoxybutane (DEB), mitomycin C (MMC) 
or cisplatin, that generate DNA crosslinks, including interstrand crosslinks (ICLs) (236-
238). ICLs affect processes that inherently require DNA unwinding and strand 
separation such as DNA replication and transcription (239). Consequently, ICLs are 
particularly deleterious if unresolved.  
Identification of mutated genes in FA patients has discovered a diverse set of 
proteins necessary for crosslink repair. Currently, sixteen FANC genes associated with 
patient mutations (FANCA-FANCQ) have been described. They constitute a common 
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DNA repair pathway, called the Fanconi Anemia Pathway, to resolve the ICLs 
encountered during replication (240, 241).  
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Figure 35: Regulatory role of FA proteins in ICL repair pathway 
(A) DNA ICL blocks two replication forks. (B) The FANCM–FAAP24–MHF1/2 complex 
recognizes the stalled replication fork and recruits the FA core complex to the ICL 
region. FANCM also initiates ATR-CHK1-dependent checkpoint response, which 
phosphorylates FANCA/E/D2/I. (C) The FA core complex, a ubiquitin E3 ligase, 
monoubiquitinates FANCD2 and FANCI, which recruits the ID heterodimeric complex 
to the ICL site. (D) FANCD2-Ub acts as a platform to recruit multiple nucleases to 
coordinate nucleolytic incisions. FANCP/SLX4, which interacts with ERCC1–XPF and 
MUS81–EME1 structure-specific nucleases, and FAN1 5’-flap endonuclease are good 
candidates for this process. Both SLX4 and FAN1 contain UBZ4, which is essential for 
FANCD2-Ub-dependent recruitment to the ICL. (E) Unhooking leaves cross-linked 
nucleotides attached to the complementary strand, which is bypassed by TLS.  
(F) HR repairs the DSB that is created by incision. Downstream FA proteins promote 
RAD51-dependent strand invasion and the resolution of recombinant intermediates. 
NER removes remaining adducts and fills the gap. (G) The USP1–UAF1 DUB complex 
removes monoubiquitin from FANCD2-I and finishes the repair. Adapted from Kim et 
al. (242) 
 
Initiation of the FA pathway occurs through formation of a heterodimer 
composed of FANCM and FAAP24 (FA-associated protein 24 kDa) (243), called the 
anchor complex. This complex recognizes the DNA lesion and recruits the FA core 
complex, consisting of seven FA proteins (FANCA/B/C/E/F/G/L) and two FA-associate 
proteins (FAAP20 and FAAP100). Aside from its function in recruitment, the FANCM-
FAAP24 complex also stabilizes the stalled replication fork and initiates ATR (ataxia-
telangiectasia and Rad3-related)-mediated checkpoint signaling (243, 244) . The stable 
association of FANCM with chromatin is maintained by the histone fold protein 1 
(MHF1) and MHF2, which also amplify the activation of the pathway (245, 246). During 
activation, multiple FA proteins are phosphorylated by ATR-CHK1 checkpoint kinases, 
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representing a close interconnection of the FA pathway with DNA damage response 
signaling (Figure 35B). 
The FA core complex, which functions as a multi-subunit ubiquitin E3 ligase 
complex, activates the monoubiquitination of the ID complex (FANCD2 and FANCI) 
after DNA damage (234). This is the key regulatory step in the pathway. The FANCL 
subunit of the core complex, which contains a RING domain, is an ubiquitin E3 ligase. 
Together with the UBE2T E2 enzyme, it conjugates a single ubiquitin to K561 and K523 
of human FANCD2 and FANCI, respectively (Figure 35C) (247, 248). The 
monoubiquitinated ID complex is recruited to DNA lesions, where it acts as a landing 
pad to recruit downstream FA proteins (D1/J/N/O/P) for ICL repair activity. Initially, 
nucleases such as FAN1 (FA associated nuclease 1) and the newly identified FA 
complementation group FANCP/SLX4 protein are recruited to the monoubiquitinated 
FANCD2 in order to initiate nucleolytic incision (Figure 35D) (249). FAN1 and SLX4 
contain a UBZ4 (ubiquitin-binding zinc finger 4) domain that can specifically recognize 
the ubiquitin moiety of FANCD2 (250, 251). SLX4-associated MUS81-EME1 and XPF-
ERCC1 nucleases promote cross-link unhooking (252) ; this unhooking process converts 
a stalled replication fork into a double-strand break (DSB). Subsequently, translesion 
synthesis (TLS) pathway bypasses the unhooked cross-linked oligonucleotides and 
restores a nascent strand (Figure 35E). The DSB is then repaired by homologous 
recombination (HR), while nucleotide excision repair (NER) excises the remaining 
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adducts, and the gap is filled by DNA polymerases (Figure 35F). In the HR process, the 
downstream FA proteins D1/J/N/O facilitate RAD51 loading and the resolution of 
recombination intermediates. Finally, the modified ID complex is deubiquitinated by the 
deubiquitinating (DUB) enzyme USP1 (ubiquitin specific peptidase 1), associated with 
its activating partner, UAF1 (USP1-associated factor 1) (Figure 35G)(253, 254). The USP1-
dependent deubiquitination constitutes another critical repair step in the completion of 
DNA ICL repair. 
4.1.2 FAAP20, an integral component of the FA core complex 
FAAP20 (FA-associated protein 20kD) is the newest member of the FA core 
complex, which was discovered very recently (255-258). FANCA/B/C/E/F/G/L are bona 
fide FA genes with hundreds of unique mutations described in the Fanconi Anemia 
Mutation Database (http://www.rockefeller.edu/fanconi/). FAAP20 is required for core 
complex assembly and function, but no disease-associated mutations have been found in 
this protein as yet (208). FAAP20 interacts with FANCA through its N-terminus 
(possibly through its WALLER motif) (256), maintains the integrity of the core complex, 
and promotes FANCD2 mono-ubiquitination (208, 256-258). The C-terminal region of 
FANCA (residues 1095-1200) is also required for interaction with FAAP20 (208, 256). The 
protein stability of FAAP20 and FANCA rely on each other. FAAP20 contains a 
ubiquitin binding zinc finger (UBZ) domain (255-258) of the UBZ2 type, though it has 
also been referred to as a UBZ4 type. The UBZ zinc finger, beginning at cysteine-147, 
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binds possibly preferentially to K63-linked poly-ubiquitin chains at sites of DNA 
damage (208, 258) and recruits monoubiquitinated REV1 in the REV1-Pol  complex, 
potentially linking the FA and translesion synthesis (TLS) pathways (198) (Figure 36). 
The UBZ domain of FAAP20 is necessary for normal FANCD2 monoubiquitination, but 
it is not involved in binding to ubiquitinated FANCD2 (60). Instead, FAAP20 may be 
particularly important for the correct recruitment of monoubiquitinated FANCD2 at the 
DNA damage site, although the importance of FAAP20 in this context appears to vary 
depending on which cell type is analyzed (258). The FA pathway is regulated by the 
ubiquitin signaling cascade initiated by RNF8 and its partner UBC13 as ubiquitin E3 and 
E2 enzyme, respectively, and mediated by FAAP20. FAAP20 preferentially binds the 
ubiquitin product of RNF8-UBC13, and this ubiquitin-binding activity and RNF8-UBC13 
are both required for recruitment of FAAP20 to ICLs (258).  
 
Figure 36: Regulation of TLS in replication-associated ICL repair. 
FAAP20 recruits TLS machinery to ICL repair by interacting with ubiquitinated Rev1 
through its UBZ domain. Adapted from Kim et al. (242) 
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4.1.3 Ubiquitin-binding zinc fingers (UBZs) in DNA repair proteins 
Ubiquitin plays a crucial role in the regulation of DNA repair processes (79). 
Ubiquitin signaling is mediated by UBDs that recognize various ubiquitin modifications. 
Among these more than 20 different UBD classes that exist to interact with various 
ubiquitin modifications (32), the UBZ family is particularly interesting because it 
exclusively appears in proteins involved in DNA ICL repair and TLS (79). The UBZ 
domain was first identified by yeast two-hybrid screening and bioinformatics analysis 
(51), characterized by short mono-nucleate Zn-fingers within their minimal interaction 
region and related to a large class of DNA-binding Zn-fingers. Among the proteins 
identified was TAX1BP1 with two copies of a C2H2-finger (259), referred as UBZ1 
(TAX1BP1-family) and the uncharacterized protein FLJ44922 (later identified as FAAP20) 
with one copy of a C2HC-finger, referred as UBZ2 (FLJ44922/FAAP20 family). A 
bioinformatics search for Zn-fingers with more similarity to UBZ1/2 than to the DNA-
binding Zn fingers revealed a number of additional UBZ candidate families, UBZ3 
through UBZ9.  
Nowadays, there are two subfamilies of UBZ domains in DNA repair pathways: 
(1) UBZ3, which contains a highly conserved C2H2 zinc finger and (2) UBZ4 which is 
defined as a RAD18-like C2HC zinc finger (Figure 37). So far, the only UBZ3 domain 
was identified in yeast Rad30 and its mammalian homolog, Pol . The NMR structure of 
the Pol  UBZ3 domain was determined (68), revealing a similar fold as the classic 
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DNA-binding zinc finger, which contains two short  strands and a  helix in which the 
ubiquitin binding surface is mapped on the -helix on the opposite side of the zinc-
coordinating residues by NMR titration and mutagenesis experiments. In contrast, the 
UBZ4 domain has been found in many proteins to be involved in DNA repair, such as 
Pol , WRNIP1 (Werner helicase-interacting protein 1), and RAD18 (79) . Pol  interacts 
with ubiquitinated PCNA, while WRNIP and RAD18 bind to K48- and K63-poly-
ubiquitin chains (201, 224, 260, 261). Additionally, many of these proteins are involved 
in ICL repair. For example, SNM1A, a mammalian ortholog of yeast Pso2, was shown to 
target a stalled replication fork by recognizing PCNA-Ub via its UBZ4 domain (262). 
Besides SNM1A, the recently identified FAN1 nuclease and the FANCP/SLX4 nuclease 
scaffold protein also contain UBZ4 domains that specifically recognize FANCD2-Ub and 
function in the downstream ICL repair process, emphasizing a specialized role of UBZ4-
containing proteins in mediating ICL repair (250, 263). So far, only two of the UBZ4 
domain structures are determined, WRNIP and RAD18 in complex with monoubiquitin 
(67). They both contain a  fold, and interact with ubiquitin in an almost identical 
mode (usage of 1 and -helix), but completely different from the predicted UBZ3-
ubiquitin interaction mode. In summary, UBZ domains are found in diverse players in 
the DNA repair signaling pathways and represent a key signature of DNA repair 
proteins that interact with ubiquitinated targets or polyubiquitin chains at DNA damage 
sites to fulfill their functions. 
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Figure 37: UBZ domains in DNA repair proteins 
Various amino acid sequences of known UBZ domains are shown, and their relative 
positions are marked as a red bar in the blue protein schematic. The conserved residues 
that comprise a zinc-binding core are shaded in the pink box.  
 
4.1.4 The FAAP20 UBZ domain 
The UBZ domain of the human FAAP20 protein is located at the C-terminus, 
from residues 144 to 173. Based on primary sequence alignment, it contains a CCHC 
motif to coordinate with the zinc ion. It is predicted to have two  strands and one -
helix to adopt the canonical zinc-finger  fold. The FAAP20 UBZ is conserved in 
higher vertebrates, but not in yeast (Figure 38).  
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Figure 38: Sequence alignment of the FAAP20 UBZ from different species. 
The conserved zinc-coordinating residues are highlighted in blue. Conserved residues 
involved in the formation of the hydrophobic core of the UBZ domain are boxed in 
orange and those involved in ubiquitin interaction are highlighted. Acidic residues are 
colored in pink and hydrophobic residues are colored in orange. 
 
The interaction of FAAP20 UBZ with ubiquitin has been probed by in vitro 
pulldown experiments. E.coli expressing WT FAAP20 can pulldown ubiquitin chains, 
while the FAAP20 containing a mutation of the zinc-coordinating cysteine to alanine 
cannot. However, the exact species of ubiquitin that interacts with FAAP20 UBZ remains 
controversial. For monoubiquitin, E.coli expressed His-Flag-FAAP20 cannot pulldown 
monoubiquitin in vitro. (255) A recombinant GST-UBZ domain also cannot pulldown 
monoubiquitin in vitro (258). However, recombinant Ubi-GST can pulldown either MBP-
FAAP20 (256) or Flag-tagged FAAP20 (257) in vitro.  With regard to the ubiquitin chain 
specificity, E.coli expressed His-Flag-FAAP20 can only pulldown K63-linked ubiquitin 
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chains, but not K48-linked ubiquitin chains (255). E.coli expressed GST-FAAP20 can 
pulldown both K48-linked and K63-linked ubiquitin chains from 293T cell lysates (256). 
A recombinant GST-UBZ domain can pulldown both K48-linked and K63-linked 
ubiquitin chains with preference toward K63-linked chains (258). Since our NMR 
titration experiments (below) clearly shows the interaction between FAAP20 UBZ and 
monoubiquitin, the discrepancy of these pulldown experiments likely reflects the 
different experimental conditions. 
FAAP20 UBZ is required for DNA-damage-induced chromatin loading of 
FANCA (255), for normal recruitment of the FA core complex and FANCD2 to ICL (258) 
and for bridging the interaction of FA complex with the translesion synthesis machinery 
(255, 258).  In particular, the FAAP20 UBZ-ubiquitin interaction has been shown to be 
essential for recruiting the monoubiquitinated Rev1(257) (Figure 36).  
4.2 Results 
4.2.1 Solution structure of the human FAAP20 UBZ domain 
In order to probe the molecular basis of ubiquitin recognition by the FAAP20 
UBZ, we first determined the solution structure of the apo protein, consisting of human 
FAAP20 residues 140-180, by NMR (Figure 39; statistics shown in Table 3). The solution 
structure of the FAAP20 UBZ domain was determined with 852 NOE, 44 dihedral angle, 
and 28 hydrogen bond constraints. Residues 144-173 of FAAP20 UBZ domain consists of 
two short antiparallel b-strands formed by residues 145-147 and 151-153, respectively, 
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and a C-terminal a-helix spanning residues 160-173, adopting a well-converged 
canonical  fold, with mean pairwise r.m.s. deviations of 0.29 and 1.11 Å  for the 
backbone and heavy atoms, respectively. The  fold is held together by zinc 
coordination of conserved “finger” residues, including C147 from 1, C150 from the 
‘fingertip’ of the 1-2 loop, and H166 and C170 from the -helix. A C147A or C150A 
mutation in the human FAAP20 UBZ domain resulted in loss of capability of interacting 
with ubiquitin, increased sensitivity to ICL agents, and inactivation of FA pathway. 
Packing of the two -strands against the -helix is augmented by interactions among 
conserved hydrophobic residues, including L144 N-terminal to β1, M149 at the fingertip 
of the β1-β2 loop, F154 C-terminal to β2, L158 N-terminal to the -helix, and V163 and 
L167 in the middle of the -helix (Figure 38). Outside of the compact  zinc-finger 
module, N-terminal residues 140-143 and C-terminal residues 174-180 are completely 
disordered.  
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Figure 39: Solution structure of the human FAAP20 UBZ 
FAAP20 UBZ adopts a canonical  fold with the -strands shown in blue, and -helix 
shown in red. Sidechains of the zinc-coordinating CCHC motif are shown in the stick 
model and colored according to the secondary structures. The zinc atom is shown in the 
sphere model and colored in purple. The backbone of the terminal tryptophan, W180, is 
colored in orange. 
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Table 3: Structural statistics of human FAAP20 UBZ domain 
Structural statistics for the human FAAP20 UBZ (10 structures)a 
FAAP20 UBZ (140-180)   
NOE distance restraints  852 
Intra-residue   144 
Sequential  246 
Medium-range (1< |i-j| 4)  278 
Long-range (|i-j|  5)  184 
Hydrogen bond constraintsb  28 
Dihedral angle constraintsc  44 
   
Target function value  1.04  0.01 
   
Ramachandran plotd   
Favored region (98%)  91.9 
Allowed region (>99.8%)  100.0 
   
Mean pairwise RMSD   
(FAAP20 UBZ 144-173)   
Backbone   0.29  0.07 Å  
Heavy Atoms   1.11  0.18 Å  
a None of these structures exhibit distance violations greater than 0.5 Å  or dihedral 
angle violations greater than 5. 
b Two constraints (dHN-O ≤ 2.5 Å and dN-O ≤ 3.5 Å) are used for each identified hydrogen 
bond. 
c Dihedral angle constraints were generated by talos+ based on backbone atom chemical 
shifts (108), and by analysis of NOE patterns. 
d MolProbity was used to assess the quality of the structures (219). 
 
 
 
4.2.2 The disordered C-terminal tail of FAAP20 UBZ is involved in 
ubiquitin binding 
After determining the apo structure of human FAAP20 UBZ domain, we went on 
to probe the FAAP20-ubiquitin interaction by NMR titration, in which we observed 
extensive resonance perturbation for a lot of residues. Surprisingly, we noticed large 
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chemical shift perturbation for the residues of the disordered C-terminal tail in addition 
to residues of the  UBZ module. The backbone resonance of the terminal Trp residue 
(W180) of FAAP20, in particular, undergoes a prominent change of chemical shift upon 
ubiquitin binding (Figure 40 left panel), indicating that it is experiencing a major 
alteration of the chemical environment and may likely be directly involved in ubiquitin 
binding.  
In order to further examine the potential involvement of the disordered C-
terminal tail in ubiquitin binding, we conducted the 1H-15N heteronuclear NOE 
experiment, looking for changes in flexibility of the FAAP20 protein backbone upon 
ubiquitin binding (Figure 40 right panel). In this experiment, a negative value of the 
heteronuclear NOE reflects rapid conformational fluctuation at the ps-to-ns timescale 
that is typically found in disordered loops, whereas a positive value reflects a lack of fast 
motions that is consistent with a rigid conformation commonly found in well-folded 
proteins (215). In the apo state, residues of the C-terminal tail of FAAP20 UBZ all 
displayed negative heteronuclear NOEs, consistent with the disordered conformation 
observed in the NMR ensemble of apo FAAP20. In contrast, these values became 
distinctly positive upon addition of 2-molar excess of ubiquitin, indicating that the C-
terminal tail has gained rigidity upon the formation of the FAAP20-ubiquitin complex. 
Taken together, these data strongly support the involvement of the C-terminal tail of 
FAAP20, in addition to the canonical UBZ domain, in interaction with ubiquitin in vitro. 
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Figure 40: C-terminal tail of human FAAP29 UBZ is involved in ubiquitin 
binding 
(left) Titration of unlabeled ubiquitin into 15N-labeled FAAP20 significantly perturbs the 
backbone amide resonance of W180. Apo FAAP20 is shown in black and FAAP20 with 
excess ubiquitin in red. (right) 1H-15N heteronuclear NOEs plotted per residue of 
FAAP20. Values for the apo FAAP20 are shown with black bars and values for the 
FAAP20 with excess ubiquitin are shown with red bars. 
 
4.2.3 Solution structure of the human FAAP20 UBZ-ubiquitin complex  
The unexpected involvement of the disordered C-terminal tail outside the 
FAAP20 UBZ for ubiquitin interaction is distinct from all other UBZ domains studied 
thus far (68, 69, 264, 265) and warrants a thorough structural investigation. Using 
sparsely-sampled 3-D and 4-D NMR spectroscopy (266), we have determined the 
solution structure of the FAAP20 UBZ-ubiquitin complex (Figure 41AB), with the 
ensemble mean pairwise r.m.s. deviations of 0.55 and 1.16 Å  for the backbone and heavy 
atoms, respectively (Table 4).  
Binding of FAAP20 causes little conformational change for ubiquitin, which 
adopts the familiar α/β-roll topology with the main -helix wrapped in a distorted 
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central β-sheet consisting of five strands (Figure 41B). At the opposite, solvent-exposed 
surface of the ubiquitin β-sheet lies a cluster of hydrophobic residues centered around 
I44Ub for high-affinity interaction with FAAP20 (Figure 41C). In contrast, binding of 
FAAP20 to ubiquitin is accompanied by a major conformational switch, involving 
binding-induced attachment of the disordered C-terminal tail of apo FAAP20 to its 
compact  zinc finger module to form an expanded ubiquitin binding interface 
(compare Figure 39 with Figure 41BD).  
The overall assembly of the FAAP20 UBZ-ubiquitin complex is similar to that of 
the MIU/IUIM-ubiquitin complex (41, 42) and to the predicted structural model of the 
Pol  UBZ-ubiquitin complex (68), with the prominent UBZ helix packing against the 
solvent-exposed surface of the central β-sheet of ubiquitin. The FAAP20 UBZ helix is 
oriented in parallel with the central β-strand (β5) of ubiquitin, and the C-terminal end of 
the UBZ helix is located in close proximity to the C-terminus of ubiquitin (Figure 39C). 
At the center of the UBZ helix lies an invariant Ala residue (A168) that wedges into the 
hydrophobic pocket of ubiquitin encircled by L8Ub, I44Ub and V70Ub. Along the same face 
of the FAAP20 helix, at one helical turn N-terminal to the central A168 (at the -4 position 
in the primary sequence, Figure 38) lies a conserved Asp residue (D164) that forms 
hydrogen bonds with the backbone of A46Ub and G47Ub, anchoring the N-terminal half of 
the UBZ helix to ubiquitin. Such a helix-ubiquitin interaction is augmented by 
hydrophobic interactions at the C-terminal half of the UBZ helix, with the invariant 
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hydrophobic residue L171 located at one helical turn C-terminal to A168 (at the +3 
position, Figure 38) along the same face of the UBZ helix to interact with I44Ub, V70Ub, 
and the side chain of R42Ub, further enhancing the binding toward ubiquitin. A group of 
less conserved residues along the UBZ helix also contribute to the human FAAP20 
interaction with ubiquitin, including S165 that forms a hydrogen bond with H68Ub, the 
sidechain of Q169 that interacts with L8Ub, and A172 that interacts with V70Ub (Figure 
41D). 
Unique to the FAAP20 UBZ-ubiquitin interface is the presence of binding-
induced folding of a disordered C-terminal tail of FAAP20 containing two invariant 
residues: Asp (D177) and Trp (W180) (Figure 38). Although residues of this tail are 
highly dynamic in the apo state as reflected by their negative heteronuclear NOE values 
(Figure 41D), they form an extended -loop that is fixated by joint interactions with 
ubiquitin and with the core module of the FAAP20 UBZ. In particular, the sidechain of 
D177 points toward the sidechains of R42Ub and R72Ub, potentially latching onto 
ubiquitin through salt bridges with these residues. W180, the Trp residue at the very C-
terminus of this tail in FAAP20, appears to play a crucial role in mediating FAAP20-
ubiquitin binding. Emanating toward I44Ub from the now extended C-terminal loop of 
FAAP20 that stretches along the UBZ-ubiquitin interface, the indole group of W180 is 
affixed to the carbonyl group of G47Ub located within the 3-4 loop of ubiquitin 
through a hydrogen bond of the W180 imino group (Figure 41E). Such an interaction is 
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supported by the observed intermolecular NOE between W180 aromatic protons and the 
H proton of K48Ub (Figure 41F, lower right panel). The W180 indole ring points toward 
I44Ub and is juxtaposed between the sidechains of K48Ub and Q49Ub of the 3-4 loop of 
ubiquitin, and P148 and M149 of the fingertip and L167 of the central helix of the 
FAAP20 UBZ. Importantly, W180, together with a cluster of conserved residues of the 
compact zinc finger module of FAAP20, including L167, A168, and L171, forms an 
encircled hydrophobic pocket around I44Ub for high-affinity ubiquitin binding (Figure 
41CD). Accordingly, numerous intermolecular NOEs are observed in the 4-D omit NOE 
(difference) spectrum between I44Ub and surrounding FAAP20 residues (Figure 41F and 
Figure 42). Highlighting the integral structure of the FAAP20 C-terminal tail in ubiquitin 
recognition, residues of this tail all display positive heteronuclear NOEs that are 
congruent with FAAP20 residues of the  zinc-finger module (Figure 41D). 
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Figure 41: Solution structure of the human FAAP20-ubiquitin complex. 
(A) Backbone traces of the NMR ensemble of 10 structures. -strands, -helices and 
loops are colored in blue, red and grey, respectively. Zinc is shown as a grey sphere. (B) 
Ribbon diagram of the complex, with FAAP20 in orange and ubiquitin in green. (C) The 
surface of FAAP20 UBZ with the interface is colored in orange. The D-A-L motif and the 
C-terminal tryptophan residue are colored in red. The sidechains of the interfacial 
residues are shown in the stick model and labeled in black. The ubiquitin is colored in 
green with the sidechains of the interfacial residues shown in the stick model. The 
central residue I44Ub is colored in blue. (D) The surface of ubiquitin with the interface is 
colored in green. The central residue I44Ub is colored in blue. The sidechains of the 
interfacial residues are shown in the stick model and labeled in black. The FAAP20 UBZ 
is colored in orange with the sidechains of the interfacial residues shown in the stick 
model. The D-A-L motif and the C-terminal tryptophan residue are colored in red. The 
two -strands and the zinc ion are not shown for clarity. (E) Interaction between 
FAAP20 W180 (orange) and ubiquitin I44, G47 and K48 (green). The interacting 
sidechains are shown in the stick model. The hydrogen bond between W180 H1 and 
G47 backbone is shown as a dashed line and the distances are labeled in blue. The 
hydrophobic interactions supported by intermolecular NOEs are shown as dashed lines 
and the distances are labeled in black. (F) Representative 2-D slices of the 4-D 13C-
HMQC-NOESY-HSQC omit spectra centered on I44 H1 and K48 H, respectively, 
illustrating the intermolecular NOEs from FAAP20 to ubiquitin I44 H1 and K48 H 
protons. Positive intermolecular NOE crosspeaks are colored in black and a negative 
diagonal peak is colored in red. Resonances of FAAP20 and ubiquitin are colored in 
orange and green, respectively. The generation of omit spectra is shown in Figure 42 in 
detail. 
 
 116 
 
Figure 42: Intermolecular NOE difference (omit) spectrum of the human 
FAAP20-ubiquitin complex 
Sparsely-sampled 4-D 13C-HMQC–NOESY–HSQC spectra were collected for the 
FAAP20-ubiquitin complex with both components or with individual components 13C-
labeled as described previously (3). Reconstruction of the difference time domain signals 
of the uniformly labeled protein complex from component-labeled samples generated an 
omit spectrum containing only intermolecular NOEs. Slight over-subtraction of time 
domain data from individual components generates negative diagonal signals (red) in 
the omit spectrum and ensures that all of the positive crosspeaks originate from 
intermolecular NOEs. Panel (A) (upper, aliphatic regions; lower, aromatic regions) 
shows sections of F1-F2 slices of the corresponding 4-D spectra centered at 13.52 ppm in 
F3 and 0.796 ppm in F4, displaying NOEs to I44Ub H1. Peaks circled by dash lines are 
off-plane signals. Panel (B) shows sections of F1-F2 slices of the corresponding 4-D 
spectra centered at 53.88 ppm in F3 and 4.764 ppm in F4 in the aromatic region, 
displaying NOEs to the ubiquitin K48 H. 
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Table 4: Structual statistics for the human FAAP20 UBZ-ubiquitin complex 
Structural statistics for the human FAAP20 UBZ-ubiquitin complex (10 structures)a 
FAAP20 UBZ (140-180)   
NOE distance restraints  1028 
Intra-residue   126 
Sequential  291 
Medium-range (1< |i-j| 4)  309 
Long-range (|i-j|  5)  302 
Hydrogen bond constraintsb  28 
Dihedral angle constraintsc  55 
Ubiquitin (1-76)   
NOE distance restraints  2867 
Intra-residue  328 
Sequential  616 
Medium-range (1< |i-j| 4)  569 
Long-range (|i-j|  5)  1354 
Hydrogen bond constraintsb  60 
Dihedral angle constraintsc  132 
Intermolecular NOE distance constraints  187 
   
Target function value  2.38  0.09 
   
Ramachandran plotd   
Favored region (98%)  90.8 
Allowed region (>99.8%)  99.3 
   
Mean pairwise RMSD   
(FAAP20 UBZ 143-180; Ubiquitin 1-74)   
Backbone   0.55  0.08 Å  
Heavy Atoms   1.16  0.08 Å  
a None of these structures exhibit distance violations greater than 0.5 Å  or dihedral 
angle violations greater than 5. 
b Two constraints (dHN-O ≤ 2.5 Å and dN-O ≤ 3.5 Å) are used for each identified hydrogen 
bond. 
c Dihedral angle constraints were generated by talos+ based on backbone atom 
chemical shifts (108), and by analysis of NOE patterns. 
d MolProbity was used to assess the quality of the structures (219). 
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4.2.4 The conserved D-A-L motif of the FAAP20 UBZ helix contributes 
to ubiquitin binding 
After determining the solution structure of the FAAP20 UBZ-ubiquitin complex, 
we investigated the FAAP20-ubiquitin interaction by isothermal titration calorimetry 
(ITC) measurements, probing the contribution of individual residues to the binding 
affinity. Titration of wild-type (WT) ubiquitin into WT FAAP20 UBZ revealed a Kd value 
of 9.26 M (Table 5), a binding affinity stronger than the affinities of most ubiquitin 
binding domain (UBD)-ubiquitin interactions. 
Table 5: Binding affinities of the human FAAP20 UBZ-ubiquitin complexes measured 
by ITC 
FAAP20 UBZ ubiquitin Kd (M) 
WT WT 9.26 
WT I44A NDB 
D164A WT NDB 
A168Y WT NDB 
L171A WT 529 
W180A WT NDB 
NDB: No detectable binding or too weak to fit reliably (Kd > 600 μM) 
Among the interface residues of the FAAP20-ubiquitin complex, I44Ub is at the 
center of the FAAP20 UBZ-ubiquitin interaction and displays numerous intermolecular 
NOEs to FAAP20 residues, including W180 of the C-terminal tail (Figure 41F and Figure 
42). Unsurprisingly, mutation of I44Ub to Ala completely abolished the ubiquitin binding 
by FAAP20, verifying that ubiquitin is being recognized through the canonical 
hydrophobic patch centered at I44Ub (Table 5, Figure 43). On the FAAP20 side, A168 is 
located at the center of the UBZ helix and plays a pivotal role in anchoring the UBZ helix 
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to the conserved hydrophobic pocket of ubiquitin formed by L8Ub, I44Ub, and V70Ub. 
Accordingly, substitution of A168 by Tyr eliminated the FAAP20-ubiquitin interaction. 
Point mutation of D164A of the FAAP20 UBZ similarly disrupted ubiquitin binding in 
our ITC studies (Table 5, Figure 43), consistent with a previous report (255). Finally, 
mutation of L171A significantly weakened the FAAP20 interaction with ubiquitin (Table 
5, Figure 43). Taken together, these observations further support the structurally 
observed binding mode of the FAAP20-ubiquitin complex, corroborating the recognition 
mode of the D-A-L motif along the surface of the UBZ -helix for ubiquitin interaction. 
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Figure 43: Mutations of the interface residues affect the FAAP20-ubiquitin binding. 
Raw data of heat change per injection and the fitted affinity curve, whenever applicable, 
are shown for (A) the ubiquitin I44A mutant, (B) the FAAP20 A168Y mutant, (C) the 
FAAP20 D164A mutant, and (D) the FAAP20 L171A mutant, respectively. 
 
4.2.5 The terminal tryptophan is required for FAAP20-ubiquitin 
binding in vitro and efficient ICL repair in vivo  
Since the FAAP20-ubiquitin interaction uniquely features an expanded 
ubiquitin-binding interface beyond the compact  zinc-finger module, with the 
absolutely conserved Trp residue (W180) of the disordered C-terminal tail of the apo 
FAAP20 participating in numerous interactions with ubiquitin residues in the protein 
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complex, including I44Ub at the center of the ubiquitin interface, we conducted in vitro 
and in vivo experiments to evaluate the consequence of a W180A mutation in affecting 
the FAAP20-ubiquitin interaction and in FA core complex mediated ICL repair. In order 
to make sure that the W180A mutation does not alter the UBZ structure, a 1H-15N HSQC 
spectrum of the FAAP20 W180A mutant was collected. With the exception of the few C-
terminal residues neighboring W180 in the primary sequence, the overall spectra of the 
WT FAAP20 UBZ and the W180A mutant are nearly superimposable, consistent with 
the notion of a disordered C-terminal tail in the apo FAAP20 and verifying that the 
W180A mutation does not disturb the  fold of the UBZ (Figure 44). Surprisingly, in 
contrast to the tight binding of the WT FAAP20 toward ubiquitin (Figure 45A), the 
W180A mutant completely abolished the FAAP20 interaction with ubiquitin in ITC 
measurements (Figure 45B), revealing that W180 not only contributes to, but is also 
required for ubiquitin binding in vitro.  
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Figure 44: 1H-15N HSQC spectra of the human FAAP20 UBZ WT protein (red) 
and W180A mutant (black). 
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Figure 45: The C-terminal tryptophan residue (W180) of FAAP20 outside the compact 
UBZ module plays an indispensable role in ubiquitin-recognition of FAAP20 in vitro 
and in efficient ICL DNA repair in vivo. 
(A) Measurement of binding affinity between the WT FAAP20 and WT ubiquitin by ITC. 
(B) Mutation of W180A in FAAP20 abolished ubiquitin binding in ITC measurements. 
(C) U2OS cells stably expressing siRNA-resistant FAAP20 wild-type, C147A & C150A 
(CA), or W180A (WA) were transfected with siRNA against FAAP20 (siF20) for 48 h, 
and cell viability was determined 6 days after the treatment of indicated doses of 
mitomycin C. (D) Immunoblot analysis of U2OS cells in (C) harvested 72 h after siRNA 
treatment. 
 
In order to assess the contribution of the C-terminal tryptophan residue in 
regulating DNA repair in vivo, we also tested the ability of full-length FAAP20 harboring 
a W180A mutation to complement the DNA damage sensitivity of the FAAP20-depleted 
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mammalian cells. The integrity of the FAAP20 UBZ motif is required for conferring 
cellular resistance to DNA ICL-inducing agent, mitomycin C (MMC) (255). Therefore, 
we replaced endogenous FAAP20 depleted by siRNA with siRNA-resistant FAAP20 
variants and challenged cells with MMC. Stable expression of siRNA-resistant WT 
FAAP20 could restore the hypersensitivity to MMC caused by FAAP20 depletion, while 
neither C147A & C150A (the mutations disrupting the zinc finger fold) nor the W180A 
mutant could rescue the DNA damage sensitization phenotype (Figure 45CD). Such an 
observation further emphasizes the functional importance of W180 and its C-terminal 
tail residing outside the core UBZ domain in mediating the FAAP20 interaction with 
ubiquitin, which is essential for the ICL DNA repair in vivo. It is intriguing to note that 
FAAP20 has 8 isoforms, but only isoforms 2 and 6 contain an intact UBZ domain with a 
C-terminal Trp residue and hence are capable of interaction with ubiquitin and 
execution of ICL DNA repair. The functions of the other isoforms, however, await to be 
determined. 
4.3 Discussion 
4.3.1 Distinct ubiquitin recognition by human FAAP20 UBZ  
Depending on the organization of the zinc coordinating residues and ubiquitin 
binding motifs in the primary sequence, UBZ domains are classified into different 
subgroups, including the UBZ3 type of zinc fingers consisting of CCHH zinc-
coordinating residues represented by the Pol  UBZ, and the UBZ4 type of zinc fingers 
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consisting of CCHC zinc-coordinating residues that are found in a variety of proteins 
involved in DNA repair activities. Structural comparison of the FAAP20 UBZ-ubiquitin 
complex to the WRNIP UBZ-ubiquitin complex (PDB 3VHT), which shares a similar 
ubiquitin-binding interface with the recently reported Rad18 UBZ-ubiquitin complex 
(67), reveals a completely different orientation of the central UBZ helix, even though the 
FAAP20 UBZ is sometimes referred to as a UBZ4 domain (198, 256), the same type as the 
UBZs of WRNIP and Rad18 (Figure 46AB). Further structural comparison shows 
ubiquitin recognition by the FAAP20 UBZ helix is actually similar to that of the 
MIU/IUIM helix in the ubiquitin-bound complex (41, 42), a binding mode that features a 
D(-4)-A(0)-L(+3) motif along the ubiquitin-recognition -helix and is also shared by the 
Pol  UBZ, a UBZ3 type of zinc finger (68) (Figure 46CD). The structural observation of a 
distinct ubiquitin binding mode of the FAAP20 UBZ from that of a UBZ4 type zinc 
finger lends further credence to the suggestion of the FAAP20 UBZ as the founding 
member of the UBZ2 family that is characterized by the CCHC zinc-coordinating 
residues and the DxHxAxCL motif (79).  
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Figure 46: Ubiquitin recognition by the human FAAP20 UBZ helix is distinct from 
that of the WRNIP UBZ, but show similarity to that of IUIM/MIU. 
Panels (A) and (B) show the ribbon diagrams of the FAAP20-ubiquitin complex (orange, 
this work) and the WRNIP UBZ-ubiquitin complex (blue, PDB 3VHT), respectively. 
Ubiquitin is shown in identical orientation and colored in grey surface with central 
interfacial residue I44 in green. (C) Overlay of the human FAAP20 UBZ (orange)-
ubiquitin (pale green) complex (this work) with IUIM/MIU (cyan)-ubiquitin (pale green) 
complex (PDB 2FIF). The conserved interfacial residues along the -helix are shown in 
sphere and indicated by arrows colored according to the sequence alignment in (D). (D) 
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Alignment of the consensus sequences of the FAAP20 UBZ domain with MIU/IUIM and 
Pol  UBZ domain. The central invariant alanine is highlighted in red, the conserved 
aspartate at the -4 position in magenta, the conserved leucine at the +3 position in purple 
and the zinc ligands in blue. 
 
4.3.2 Binding-induced folding of the C-terminal tail of the human 
FAAP20 UBZ domain 
All of the UBZ fingers that have been characterized thus far interact with 
ubiquitin exclusively through the compact  zinc finger module. FAAP20 also 
contains a well-defined UBZ, together with a C-terminal tail that is disordered in the 
absence of ubiquitin. Unexpectedly, the structural elucidation of the FAAP20-ubiquitin 
complex reveals a binding-induced folding of the disordered C-terminal tail of FAAP20 
that expands the ubiquitin-binding interface beyond the canonical UBZ module for 
high-affinity interaction with ubiquitin. In particular, the very C-terminal Trp residue 
(W180), upon transforming the disordered tail of FAAP20 into an extended -loop, 
buries its sidechain into the interface of the FAAP20 UBZ and ubiquitin to fortify the 
FAAP20-ubiquitin interaction. The FAAP20 mutant with alanine substitution of the 
terminal Trp residue (W180A) abolishes ubiquitin binding in vitro and ICL DNA repair 
activity in vivo, emphasizing the crucial contribution of the FAAP20 C-terminal tail to 
FAAP20 function and highlighting a unique binding mode not observed in any of the 
previously characterized UBZ-ubiquitin complexes.  
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4.4 Materials and Methods 
4.4.1 Molecular cloning 
The DNA sequence of residues 140-180 of human FAAP20 was synthesized; the 
PCR-amplified DNA was double digested and ligated into a modified pET15 vector 
(EMD Biosciences, Inc.) between the NdeI and XhoI restriction sites. The final construct 
contained an N-terminal His10 tag, followed by a GB1 solubility enhancement tag (225). 
A TEV cleavage site is engineered between the GB1 tag and the FAAP20 sequence. The 
ubiquitin construct is the same as used in Chapter 3. The presence of the correct inserts 
of these constructs was confirmed by DNA sequencing. 
4.4.2 Protein purification 
The purification of ubiquitin is the same as described in Chapter 2. The His10-
GB1-fused FAAP20 construct was overexpressed in Escherichia coli BL21 (DE3*) cells 
(Invitrogen). Bacterial cells were cultured in M9 minimal media using 15N-NH4Cl and 
13C-glucose as the sole nitrogen and carbon sources (Cambridge Isotope Laboratories), 
and induced by IPTG (0.1 mM IPTG at 20 °C for 18 hr). 50 M ZnSO4 was added to the 
cell culture at the time of induction. The overexpressed proteins were purified by a Ni2+-
NTA column; then the N-terminal His10-GB1 tag of the FAAP20 construct were removed 
by TEV (homemade) cleavage, respectively. Another Ni2+-NTA column was used to 
remove the His10-GB1-tag and the His6-TEV protease from the UBZ. The UBZ protein 
was further purified by size-exclusion chromatography (Superdex 75, GE Healthcare).  
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4.4.3 NMR sample preparation and data collection 
NMR samples of the apo FAAP20 UBZ and the FAAP20 UBZ-ubiquitin complex 
were exchanged into an NMR buffer containing 25 mM sodium phosphate, 100 mM KCl, 
and 10% D2O or 100% D2O (pH=7.0) and concentrated to a final protein concentration of 
3 mM of FAAP20 alone or with 1:1 molar ratio of FAAP20 and ubiquitin, respectively.  
NMR experiments were conducted at 25 °C using Agilent INOVA 600 or 800 
MHz spectrometers. Four pairs of sparse-sampled 3-D triple-resonance experiments 
were collected for backbone resonances assignment. 4-D sparsely-sampled HC(co)NH-
TOCSY and HCCH-TOCSY experiments were collected for the side-chain resonances 
assignment. The traditional 3-D 15N-separated NOESY-HSQC experiments and the 4-D 
sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 13C-HMQC-NOESY-HSQC 
experiments using a uniformly 15N, 13C-labeled sample were collected for NOE 
assignments.  
NMR data were processed by NMRPIPE (151) and SCRUB (141). NMR spectra were 
analyzed with XEASY (153) and  SPARKY (152).  
4.4.4 Generation of 4-D omit spectra and identification of 
intermolecular NOEs 
For intermolecular NOE identification, three identical 4-D 13C HMQC-NOESY-
HSQC experiments were recorded for each sample (uniformly 15N, 13C-labeled, ubiquitin 
selectively labeled and UBZ selectively labeled). Each experiment used a mixing time of 
150ms, with spectral widths of 70ppm for the 13C dimensions (t1 and t3) and 10ppm for 
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the 1H(t2) dimension and t max of 4.60ms for the 13C (t1 and t3) dimensions and 11.70ms 
for the 1H (t2) dimension. Each experiment was recorded for 86 hr. The omit spectrum 
was generated by subtracting scaled FIDs of UBZ-labeled complexes and ubiquitin-
labeled complex from those of the uniformly-labeled complex with the scaling factor of 
1.05 and 1.17, respectively and reconstructed by SCRUB (141). Intermolecular NOE 
crosspeaks from the omit spectrum were analyzed manually.  
4.4.5 Structure calculation 
For apo FAAP20, NOEs identified from 3-D 15N-separated NOESY-HSQC, 4-D 
sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 13C-HMQC-NOESY-HSQC 
experiments were used for automatic CYANA (149) structure calculation and refinement 
in the presence of dihedral angle constraints derived from TALOS+ (108) analysis of 
chemical shift information. The final structural ensembles (10 structures) of apo FAAP20 
display no NOE violations > 0.5 Å  and no dihedral angle violations > 5 °. The statistics of 
the structural ensemble is shown in Table 3. The apo FAAP20 structure has been 
deposited in RCSB and BMRB (PDB ID: 2muq; BMRB ID: 25229). 
For the FAAP20-ubiquitin complex, intermolecular NOEs were identified from 
the 4-D omit spectra as described previously. Intermolecular NOE crosspeaks were 
analyzed manually and converted into distance constraints using the calibration module 
in CYANA (149). NOE crosspeaks from 3-D 15N-separated NOESY-HSQC and 4-D 
sparsely-sampled 13C-HMQC-NOESY-15N-HSQC and 13C-HMQC-NOESY-HSQC using a 
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uniformly labeled complex sample were used for automatic CYANA (149) structure 
calculation and refinement in the presence of manually assigned intermolecular NOE 
constraints and dihedral angle constraints derived from TALOS+ (108) analysis of 
chemical shift information. The final structural ensembles (10 structures) of the FAAP20 
UBZ-ubiquitin complex display no NOE violations > 0.5 Å  and no dihedral angle 
violations > 5 °. The statistics of the structural ensemble is shown in Table 4. The 
FAAP20-ubiquitin complex structure has been deposited in RCSB and BMRB (PDB ID: 
2mur; BMRB ID: 25230). 
4.4.6 Isothermal titration calorimetry  
The wild-type or mutant human ubiquitin sample (final concentrations in the 2–3 
mM range) was titrated into a solution of FAAP20 (wild-type and mutants, 0.2–0.3 mM 
range) in a buffer containing 25 mM sodium phosphate, 100 mM KCl, pH 7.0. Twenty-
eight injections of 10 μl each were performed at 25 °C using a VP-ITC Microcalorimeter 
(GE Healthcare), and data were analyzed using the Origin software assuming one-site 
binding (Origin Lab). 
4.4.7 Heteronuclear NOE experiment 
The samples for the heteronuclear 1H-15N NOE (215) experiment were prepared 
by mixing 1mM uniformly 15N-labeled FAAP20 with non-labeled ubiquitin in two 
different ratios, 1:0 (apo) and 1:2, using the same buffer condition in the NMR structural 
study. The 1H-15N NOE values were calculated from the ratios of peak intensities in the 
 132 
saturated versus unsaturated spectra. This work was done by Qinglin Wu (Zhou Lab, 
Duke University) 
4.4.8 Cell culture, plasmid construction and transfection, siRNA 
U2OS and 293T cells were cultured in Dulbecco’s Modified Eagles Medium 
supplemented with 10% fetal bovine serum (FBS) following standard culture conditions 
and procedures. Generation of FAAP20 constructs was described previously (257). Point 
mutations were introduced by QuikChange II XL Site-Directed Mutagenesis Kit (Agilent 
Technologies) and confirmed by DNA sequencing. Stable U2OS cells were generated by 
retroviral transduction of siRNA-resistant pMSCV-Flag-HA-FAAP20 variants followed 
by 2 g/mL puromycin selection.  
Plasmid transfection for retroviral transduction was performed using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocols. siRNA 
duplexes were synthesized by Qiagen and transfected using Lipofectamine RNAiMAX 
(Invitrogen). The targeting sequence for FAAP20 is 5′-
CACGGTGAGCCCGGAGCTGAT, and the nucleotides changed in the siRNA-resistant 
construct are shown in lower cases, 5′-gACtGTtAGtCCtGAaCTaAT. 
4.4.9 Protein analysis and antibodies 
Cells were lysed with NETN300 buffer (300 mM NaCl, 0.2 mM EDTA, 50 mM 
Tris [pH 7.5], 1 % NP40) supplemented with protease inhibitor cocktail (Roche). Cellular 
lysates were resolved by NuPAGE (Invitrogen) gels and transferred onto PVDF 
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membrane (EMD Millipore) followed by immunoblotting using antibodies as indicated: 
anti-FANCA (Bethyl), anti-FAAP20 (Sigma Atlas), and anti-Tubulin (Sigma). Signals 
were detected by either enhanced chemiluminescence method (Western Lightening, 
Perkin Elmer) or LAS-4000 Imaging system (GE Healthcare Life Sciences). 
4.4.10 Cytotoxicity assay 
siRNA-treated U2OS cells were seeded on 96-well plates and treated with 
increasing doses of mitomycin C (Sigma) the following day. Cell viability was 
determined using the Cell Titer-Glo Luminescence Cell Viability Assay kit (Promega) 
and Spectramax M5 (Molecular Devices) 6 days following continued drug treatment. 
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5. Conclusions and future Studies 
5.1 Conclusions 
Protein-protein interactions play important roles in almost every aspect of the 
cellular processes, by regulating the function of signaling pathways or assembling the 
protein machinery. Structural analysis of protein complexes can provide atomic 
information about the functions and regulatory mechanisms of the protein complexes. 
Additionally, the structure information of protein complexes can be used for developing 
novel therapeutics, transforming basic science knowledge to clinical drugs.  
The advancement of NMR technology has greatly enhanced the sensitivity of 
NMR experiments and has made it increasingly feasible to determine high-resolution 
structures of protein complexes that play important roles in various cellular processes by 
solution NMR. In comparison with the well-established procedure to determine the 
high-resolution structure of a single-chain protein, structure determination of a protein 
complex presents unique challenges. In particular, the limited number of interfacial 
NOEs that define macromolecular complexes require reliable detection and 
unambiguous assignment to ensure the proper assembly of individual components of 
the protein complex. The recent development of fast acquisition of high-resolution 4-D 
NOESY experiments based on sparse time-domain sampling and high-performance 
spectral reconstruction in the frequency domain offers a convenient solution to this 
challenge. In this dissertation, I present a new strategy for reliable detection and 
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assignment of intermolecular NOEs by 4-D difference NMR experiments for structure 
determination of protein complexes. This strategy can generate high-sensitivity, high-
resolution 4-D “omit” spectrum containing only intermolecular NOEs. It overcomes the 
incomplete suppression of intramolecular NOEs in the half-filtered experiment, and thus 
guarantees the cleanness of the omit spectrum. Each NOE crosspeak in the omit 
spectrum can be identified based on two chemical shift parameters: proton and the 
attached carbon attached to the proton, which dramatically reduces the assignment 
ambiguity.  
The impact of such a strategy was first demonstrated in automated structure 
determination of the homooligomer foldon complex. We show that intermolecular 
NOEs derived from the 4-D omit spectrum can be used for automated structural 
analysis of the foldon complex, and the calculated structure overlay perfectly with the 
crystal structure. In contrast, the automated structural analysis using intermonomer 
NOE information extracted from traditional 3-D half-filtered experiment failed to 
converge, most likely due to the interference of incompletely suppressed intramolecular 
NOEs and signal degeneration in the indirect 1H dimension. 
By applying this new strategy and other 4-D fast NMR based experiments, we 
next studied the molecular mechanism of ubiquitin recognition in DNA damage 
response by determining two ubiquitin-UBD complex structures: human Pol  UBM1-
ubiquitin complex and human FAAP20 UBZ-ubiquitin complex. Due to the -helical 
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property and large portion of loop region in the UBM1 domain, spectrum overlapping 
hindered accurate and reliable data analysis with conventional 3-D experiments. The 
usage of 4-D fast NMR techniques resolved this problem to a great extent, giving better 
signal separation and clean detection of NOE crosspeaks. The human Pol  UBM1-
ubiquitin complex structure was determined at high-resolution, revealing a novel helix-
turn-helix fold of UBM1 for interacting with the solvent-exposed -sheet of ubiquitin, 
centering on L8 instead of the canonical I44 of ubiquitin.  
Also by using 4-D fast NMR and 4-D omit NOE techniques, we determined the 
human FAAP20 UBZ-ubiquitin complex structure, which is a critical linkage between 
the Fanconi anemia pathway and TLS that fulfills the function of DNA interstrand 
crosslink repair. FAAP 20 contains a classical  zinc-finger module with conserved 
CCHC motif coordinating the zinc ion. We showed that the FAAP20-ubiquitin 
interaction extends beyond the canonical UBZ domain and is accompanied by 
transforming the disordered C-terminal tail of FAAP20 into a rigid -loop, with the 
invariant C-terminal tryptophan (W180 of human FAAP20) emanating toward I44Ub for 
enhanced binding. From the 4-D omit spectrum, we detected several confident 
intermolecular NOEs from W180 of FAAP20 with I44 and K48 of ubiquitin, supporting 
interaction between the FAAP20 C-terminal tail and ubiquitin. This binding-induced 
folding of the C-terminal tail outside the UBD domain reveals a novel ubiquitin 
recognition mode, which likely contributes to ubiquitin-chain specificity and to the 
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higher binding affinity between ubiquitin and UBDs. Again, the use of 4-D omit NOE 
spectroscopy has enabled unambiguous detection of numerous intermolecular NOEs, 
including the C-terminal tryptophan residue, of FAAP20 toward ubiquitin. 
5.2 Future directions 
The small sizes of UBDs make them ideal systems for structural analysis of their 
ubiquitin-bound complexes by solution NMR. It will be interesting to apply the 4-D fast 
NMR technique to larger protein complex systems.  Similar 4-D noesy experiments 
based on fast NMR have been successfully applied to structural studies of several 
proteins in our lab, including Ssu72 (141, 267), HCAII (141) and MBP (268), proving the 
feasibility of applying 4-D noesy experiments to protein sizes of up to 42kDa. The 4-D 
omit spectrum present in this thesis has better signal-to-noise ratio compared to normal 
4-D C noesy spectrum. This is because 1) the strongest diagonal signals have been 
removed which reduces the strongest aliasing artifacts that comes with the diagonal 
signals; and 2) the intramolecular NOEs have been removed, which dramatically 
reduces the total number of peaks in the spectrum, also resulting many fewer aliasing 
artifacts.  Therefore, it is feasible to apply the 4-D omit NOE spectrum strategy to larger 
protein complexes, which can take advantage of better signal separation of 4-D fast 
NMR to facilitate data analysis of large protein complex systems. Membrane protein 
complexes will be another important field for the application of 4-D fast NMR. The 
structural discrepancy of the DAGK trimeric complex clearly highlights such a need. By 
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applying advanced 4-D fast NMR techniques to this system, we might be able to detect 
and assign key intersubunit NOEs to resolve the controversy of the NMR structure. 
Although the requirement of detergent micelle for membrane proteins increases the 
molecular weights of the protein-micelle complexes dramatically, which may negatively 
impact the application of fast NMR studies due to rapid signal relaxation, recent 
demonstration of fast NMR experiments of large membrane proteins in detergent 
micelles and nanodiscs suggests the feasibility of detailed structural analysis of DAGK 
by 4-D fast NMR experiments, including omit NOE experiments described here.  
Ubiquitin recognition plays an important regulation role in DNA damage 
response pathways. One critical feature of ubiquitination is the diversity of the ubiquitin 
chain due to different types of possible linkages and different numbers of ubiquitin 
moieties within a chain. Our studies of the UBM and UBZ domains have so far been 
restricted to monoubiquitin interactions, though there is a growing body of evidence to 
suggest that many DNA repair proteins are capable of recognizing polyubiquitin chains, 
in particular K63-linked polyubiquitin chains that have been implicated as being 
recognized by both UBM and UBZ. Whether these domains are capable of recognizing 
K63 ubiquitin chains independently or in cooperation with another ubiquitin binding 
domain remains to be elucidated. In particular, our FAAP20 UBZ-ubiquitin complex 
structure shows the utilization of the C-terminal tail of FAAP20 for ubiquitin recognition 
that extends the interface to encompass K48 of ubiquitin. This suggests the possible 
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structural basis for linkage type specificity of FAAP20-ubiquitin interaction because the 
K48 linkage might be blocked by the interaction between the C-terminal tail of FAAP20 
and ubiquitin. Extended structural studies of FAAP20 UBZ in complex with K48 or K63-
linked diubiquitin will provide evidence for this hypothesis.  These studies will shed 
new insights into the regulation of DNA repair pathways, and they will undoubtedly 
benefit from novel NMR methodology such as fast NMR and high-resolution 4-D omit 
NOE spectroscopy as described in this dissertation.  
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